<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Nat Commun</journal-id><journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id><journal-title-group><journal-title>Nature Communications</journal-title></journal-title-group><issn pub-type="epub">2041-1723</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40000651</article-id><article-id pub-id-type="pmc">PMC11861323</article-id>
<article-id pub-id-type="publisher-id">57155</article-id><article-id pub-id-type="doi">10.1038/s41467-025-57155-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>KAT6B overexpression rescues embryonic lethality in homozygous null KAT6A mice restoring vitality and normal lifespan</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3322-9701</contrib-id><name><surname>Bergamasco</surname><given-names>Maria. I.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Yuqing</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Garnham</surname><given-names>Alexandra L.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1970-6236</contrib-id><name><surname>Sheikh</surname><given-names>Bilal N.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9221-2892</contrib-id><name><surname>Smyth</surname><given-names>Gordon K.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3853-9381</contrib-id><name><surname>Voss</surname><given-names>Anne. K.</given-names></name><address><email>avoss@wehi.edu.au</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7623-8344</contrib-id><name><surname>Thomas</surname><given-names>Tim</given-names></name><address><email>tthomas@wehi.edu.au</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01b6kha49</institution-id><institution-id institution-id-type="GRID">grid.1042.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0432 4889</institution-id><institution>The Walter and Eliza Hall Institute of Medical Research, </institution></institution-wrap>Parkville, VIC Australia </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01ej9dk98</institution-id><institution-id institution-id-type="GRID">grid.1008.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 088X</institution-id><institution>Department of Medical Biology, </institution><institution>The University of Melbourne, </institution></institution-wrap>Parkville, VIC Australia </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00cfam450</institution-id><institution-id institution-id-type="GRID">grid.4567.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0483 2525</institution-id><institution>Helmholtz Institute for Metabolic, </institution><institution>Obesity and Vascular Research (HI-MAG) of the Helmholtz Center Munich, </institution></institution-wrap>Leipzig, Germany </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03s7gtk40</institution-id><institution-id institution-id-type="GRID">grid.9647.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 7669 9786</institution-id><institution>Medical Faculty, </institution><institution>University of Leipzig, </institution></institution-wrap>Leipzig, Germany </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01ej9dk98</institution-id><institution-id institution-id-type="GRID">grid.1008.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 088X</institution-id><institution>School of Mathematics and Statistics, </institution><institution>University of Melbourne, </institution></institution-wrap>Parkville, VIC Australia </aff></contrib-group><pub-date pub-type="epub"><day>25</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>16</volume><elocation-id>1958</elocation-id><history><date date-type="received"><day>26</day><month>10</month><year>2023</year></date><date date-type="accepted"><day>10</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Closely related genes typically display common essential functions but also functional diversification, ensuring retention of both genes throughout evolution. The histone lysine acetyltransferases KAT6A (MOZ) and KAT6B (QKF/MORF), sharing identical protein domain structure, are mutually exclusive catalytic subunits of a multiprotein complex. Mutations in either <italic>KAT6A</italic> or <italic>KAT6B</italic> result in congenital intellectual disability disorders in human patients. In mice, loss of function of either gene results in distinct, severe phenotypic consequences. Here we show that, surprisingly, 4-fold overexpression of <italic>Kat6b</italic> rescues all previously described developmental defects in <italic>Kat6a</italic> mutant mice, including rescuing the absence of hematopoietic stem cells. <italic>Kat6b</italic> restores acetylation at histone H3 lysines 9 and 23 and reverses critical gene expression anomalies in <italic>Kat6a</italic> mutant mice. Our data suggest that the target gene specificity of KAT6A can be substituted by the related paralogue KAT6B, despite differences in amino acid sequence, if KAT6B is expressed at sufficiently high levels.</p></abstract><abstract id="Abs2" abstract-type="web-summary"><p id="Par2">KAT6A and KAT6A are epigenetic regulators with critical functions in embryonic development. Mutations in either KAT6A or KAT6B result in distinct congenital disorders in human patients. Surprisingly, overexpression of KAT6B can rescue loss of KAT6A.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Epigenetics</kwd><kwd>Development</kwd><kwd>Embryology</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100000925</institution-id><institution>Department of Health | National Health and Medical Research Council (NHMRC)</institution></institution-wrap></funding-source><award-id>1160517; 2010711</award-id><award-id>1154970</award-id><award-id>1081421, 1176789</award-id><principal-award-recipient><name><surname>Smyth</surname><given-names>Gordon K.</given-names></name><name><surname>Voss</surname><given-names>Anne. K.</given-names></name><name><surname>Thomas</surname><given-names>Tim</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par3">In eukaryotic cells, transcription is influenced by the nucleosomal barriers imposed by histone proteins. Post-translational modifications of chromatin, for example histone acetylation, regulate chromatin structure and influence the nucleosome landscape such as to promote or suppress the expression of target loci<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Lysine acetylation is catalysed by acetyltransferase enzymes and generally associated with increased gene expression and the regulation of fundamental cellular functions<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref></sup> Three families of histone acetyltransferases, with well-described acetylation domains<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup>, are currently defined based on structural and sequence conservation: the MYST family<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>, the GNAT family<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> and the p300/CBP family<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>.</p><p id="Par4">Interestingly, histone lysine acetyltransferases typically occur as pairs of highly similar proteins. MYST family members KAT6A (MOZ) and KAT6B (QKF/MORF) share identical domain structure and high sequence similarity across all functional domains<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Likewise, both the GNAT family proteins, KAT2A (GCN5) and KAT2B (PCAF)<sup><xref ref-type="bibr" rid="CR9">9</xref></sup> and the p300/CBP family proteins KAT3A (CBP) and KAT3B (P300)<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup> share identical domain structure and high sequence similarity across all functional domains. Sequence and structural similarities between family members likely resulted from ancestral gene duplication events and subsequent neofunctionalisation<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. Indeed, in vivo studies have demonstrated that these proteins have acquired independent functions<sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR14">14</xref></sup>; however, the extent to which one protein within a pair of closely related chromatin regulatory proteins can replace the other, has not been assessed.</p><p id="Par5">KAT6A and KAT6B are mutually exclusive catalytic subunits of a shared multi-protein complex including chromatin adaptor proteins of the BRPF family, primarily BRPF1, ING family, ING5 and ING4, and MEAF<sup><xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR16">16</xref></sup>. Both proteins have been shown to acetylate H3K9 and H3K23 in a range of cell and tissue systems<sup><xref ref-type="bibr" rid="CR17">17</xref>&#x02013;<xref ref-type="bibr" rid="CR23">23</xref></sup>. The <italic>KAT6A</italic> and <italic>KAT6B</italic> genes are oncogenes. KAT6A (<italic>MOZ</italic>, monocytic leukaemia zinc finger gene) was originally identified in an aggressive form of acute myeloid leukaemia resulting from a translocation fusing it to KAT3A<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. A number of other recurrent translocations of the <italic>KAT6A</italic> locus have since been identified in leukaemia with a variety of translocation partners<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. Interestingly, loss of just one allele of <italic>KAT6A</italic> greatly enhances survival and disease latency in a mouse model of MYC driven lymphoma<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. Similarly, <italic>KAT6B</italic> translocations have been identified in leukaemia and leiomyomata<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR28">28</xref></sup>. <italic>KAT6A</italic> and <italic>KAT6B</italic> mRNAs are commonly upregulated across a range of different cancer types<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. This association with cancer has fuelled the development of drugs targeting both KAT6A and KAT6B proteins<sup><xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>, which have shown promise in clinical trials<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>.</p><p id="Par6">In human patients, de novo mutations in <italic>KAT6A</italic> or <italic>KAT6B</italic> result in congenital disorders defined by cognitive impairment, developmental delay and craniofacial dysmorphogenesis<sup><xref ref-type="bibr" rid="CR33">33</xref>&#x02013;<xref ref-type="bibr" rid="CR36">36</xref></sup>. Heterozygous mutations in the <italic>KAT6A</italic> gene result in Arboleda-Tham syndrome (ARTHS)<sup><xref ref-type="bibr" rid="CR33">33</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>, while mutations in the <italic>KAT6B</italic> gene result in the Say-Barber-Biesecker-Young Simpson variant of Ohdo syndrome (SBBYSS)<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> or Genitopatellar syndrome (GPS)<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>.</p><p id="Par7">Deletion of the <italic>Kat6a</italic> or <italic>Kat6b</italic> gene in mice has identified their unique functions during development. Most <italic>Kat6b</italic><sup><italic>gt/gt</italic></sup> mice, deficient in 90% of <italic>Kat6b</italic> mRNA, die at birth on a 129&#x02009;Sv inbred genetic background, while the 20% surviving <italic>Kat6b</italic><sup><italic>gt/gt</italic></sup> mice show a failure to thrive, short stature and a squared skull<sup><xref ref-type="bibr" rid="CR37">37</xref>,<xref ref-type="bibr" rid="CR38">38</xref></sup>. <italic>Kat6b</italic><sup><italic>gt/gt</italic></sup> mice show abnormalities of the brain, including a reduced number of GAD67-positive interneurons and reduced numbers of layer V pyramidal neurons<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>, as well as fewer neural stem cells (NSCs) in the adult subventricular zone. <italic>Kat6b</italic><sup><italic>gt/gt</italic></sup> NSCs show reduced proliferation and self-renewal and a reduced capacity to differentiate into neurons<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>.&#x000a0;Mice homozgous for a null allele&#x000a0;of <italic>Kat6b</italic> show premature ossification and increased bone density in the skull and long bones<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. <italic>Kat6b</italic><sup><italic>+/&#x02212;</italic></sup> show learning and memory defects that can be ameliorated by increasing histone acetylation<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. These findings suggest that KAT6B function is primarily required for normal brain, craniofacial and skeletal development. Consistently, <italic>Kat6b</italic> is most strongly expressed in the primordia of these tissues during embryonic development<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>.</p><p id="Par8">Loss of KAT6A, either through deletion of the carboxy terminus or deletion of exons 5 to 9<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR18">18</xref></sup>, results in lethality at embryonic day (E) 14-18, depending on the genetic background<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>, an absence of transplantable haematopoietic stem cells (HSCs)<sup><xref ref-type="bibr" rid="CR42">42</xref>,<xref ref-type="bibr" rid="CR43">43</xref></sup>, an extensive anterior homeotic transformation<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, cleft palate<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR44">44</xref></sup> and cardiac and large vessel defects<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR45">45</xref></sup>. The roles of KAT6A within the foetal haematopoietic system, have been shown to depend upon its histone acetyltransferase function<sup><xref ref-type="bibr" rid="CR46">46</xref>,<xref ref-type="bibr" rid="CR47">47</xref></sup>. These tissues are not affected in mice lacking KAT6B, with the exception of a reduction, but not absence of hematopoietic stem cells in <italic>Kat6b</italic><sup><italic>&#x02212;/&#x02212;</italic></sup> embryos<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>.</p><p id="Par9">The recent development of drugs targeting both KAT6A and KAT6B has highlighted the need to better understand the cellular functions of these chromatin regulators. While it is clear from single knockout studies that one factor within the pair cannot compensate for the other at endogenous levels, it remains to be determined if there are truly unique, non-redundant functions of these proteins. To assess this, we overexpressed <italic>Kat6b</italic> mRNA 4-fold above endogenous levels in mice lacking <italic>Kat6a</italic>. We show here that <italic>Kat6b</italic> overexpression can restore all anomalies previously described in <italic>Kat6a</italic> mutant mice, including the 100% penetrant lethality, gene expression anomalies and histone acetylation deficits at histone lysine targets perturbed by loss of KAT6A. These data indicate that KAT6B can completely replace loss of essential KAT6A functions, if expressed at sufficiently high levels, despite KAT6B not normally regulating critical processes dependent on KAT6A.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>Structure and expression of KAT6A and KAT6B</title><p id="Par10">KAT6A and KAT6B have identical protein domain structures and high sequence similarity in all functional domains (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>). During development, <italic>Kat6a</italic> mRNA is&#x000a0;expressed at higher levels than <italic>Kat6b</italic> mRNA (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b</xref>). Heterozygous mutations in the human <italic>KAT6A</italic> gene result in ARTHS<sup><xref ref-type="bibr" rid="CR33">33</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>, while mutations in the <italic>KAT6B</italic> gene result in the Say-Barber-Biesecker-Young-Simpson variant of Ohdo syndrome (SBBYSS)<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> or&#x000a0;genitopatellar syndrome&#x000a0; (GTPTS)<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. Despite being clinically distinct, there is notable overlap in the clinical presentation across these disorders (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">1b</xref>; Supplementary Data&#x000a0;<xref rid="MOESM3" ref-type="media">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><title><italic>Kat6b</italic> overexpression restores histone acetylation and cell proliferation in <italic>Kat6a</italic><sup>&#x02013;/&#x02013;</sup><italic>Tg(Kat6b)</italic> fibroblasts and histone acetylation in <italic>Kat6a</italic><sup>&#x02013;/&#x02013;</sup><italic>Tg(Kat6b)</italic> embryos.</title><p><bold>a</bold> Schematic of <italic>KAT6A</italic> and <italic>KAT6B</italic> mRNA with exon structure and protein domains/regions encoded are shown in colour. White boxes indicate an uncharacterised region. The percentage amino acid sequence similarity between protein domains is indicated. Non-coding exons are indicated in grey. <bold>b</bold>
<italic>Kat6a</italic> and <italic>Kat6b</italic> mRNA levels from RNA-seq experiments analysing E8.5 embryos<sup><xref ref-type="bibr" rid="CR75">75</xref></sup>, E9.5 embryos (this work), E10.5 embryos<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>, E10.5 pharyngeal arches<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>, E10.5 heart<sup><xref ref-type="bibr" rid="CR75">75</xref></sup>, E12.5 MEFs<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>, E14.5 LSK cells<sup><xref ref-type="bibr" rid="CR76">76</xref></sup>. <bold>c</bold> Western immunoblot detecting histone H3 acetylated on lysine 23 (H3K23ac) and pan-H3 as a loading control in acid extracted histones from E14.5 mouse embryonic fibroblasts (MEFs). Each lane represents histones from MEFs isolated from an individual E14.5 foetus. 250&#x02009;ng protein loaded per lane. <bold>d</bold> Quantification of the western immunoblot in (<bold>a</bold>). Each circle represents one lane of the immunoblot in (<bold>a</bold>). <bold>e</bold> Cumulative growth curve of MEFs isolated from <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> and <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b</italic>) E14.5 foetuses, passages 0&#x02013;10. <bold>f</bold> Representative images of MEFs from <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> and <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b</italic>) E14.5 foetuses at passage 3. Scale bar&#x02009;=&#x02009;50&#x02009;&#x003bc;m. <bold>g</bold>&#x02013;<bold>j</bold> Western immunoblot detecting H3K9ac (<bold>e</bold>) and H3K23ac (<bold>g</bold>) with pan-H3 as a loading on acid extracted histones from E9.5 embryos. Each lane represents histones from an individual E9.5 embryo. 500&#x02009;ng (<bold>g</bold>) or 250&#x02009;ng () (<bold>i</bold>)&#x000a0;protein loaded per lane. Quantification of (<bold>g</bold>) in (<bold>h</bold>) and of (<bold>i</bold>) in (<bold>j</bold>). <bold>k</bold> Representative images of E9.5 <italic>Kat6b</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> and <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> embryos. Scale bar&#x02009;=&#x02009;1&#x02009;mm. <italic>N</italic>&#x02009;=&#x02009;3&#x02013;8 embryos or foetuses per genotype (<bold>a</bold>), MEF cultures derived from 3 foetuses per genotype (<bold>c</bold>, <bold>d</bold>, <bold>e</bold>, <bold>f</bold>). 3 embryos per genotype (<bold>g</bold>, <bold>h</bold>, <bold>i</bold>, <bold>j</bold>, <bold>k</bold>). Circles represent individual embryos or foetuses (<bold>b</bold>, <bold>d</bold>, <bold>h</bold>, <bold>j</bold>). Data are presented as mean&#x02009;&#x000b1;&#x02009;s.e.m. and were analysed using a one-way ANOVA with Dunnett post hoc correction (<bold>b</bold>, <bold>g</bold>, <bold>i</bold>) or two-way ANOVA with Sidak post-hoc correction (<bold>c</bold>). Drawings&#x000a0;created in BioRender, Bergamasco, M. (2025) <ext-link ext-link-type="uri" xlink:href="https://BioRender.com/m13f247">https://BioRender.com/m13f247</ext-link>.</p></caption><graphic xlink:href="41467_2025_57155_Fig1_HTML" id="d33e952"/></fig></p><p id="Par11">To test if transgenic overexpression of the <italic>Kat6b</italic> gene was able to rescue the phenotypic anomalies resulting from loss of the <italic>Kat6a</italic> gene, we generated transgenic mice overexpressing the <italic>Kat6b</italic> gene from <italic>pBACe3.6</italic> clone <italic>RP23-360F23</italic>. This clone contained all coding exons as well as 21&#x02009;kb 5 prime and 42&#x02009;kb 3 prime of the expressed sequence (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">1a, b</xref>). Seven copies of the <italic>pBACe3.6</italic> inserted into the mouse genome, resulting in the <italic>Tg(Kat6b)</italic> allele, which caused a 4-fold increase in <italic>Kat6b</italic> mRNA levels (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">1c</xref>). Mice were maintained on an FVB x BALB/c hybrid background as <italic>Kat6b</italic> overexpressing mice were not viable on inbred backgrounds.</p><p id="Par12">To assess the potential of KAT6B to compensate for KAT6A, we crossed <italic>Tg(Kat6b)</italic> heterozygous mice to mice lacking exons 5&#x02013;9 of <italic>Kat6a</italic> (<italic>Kat6a</italic><sup><italic>+/&#x02013;</italic></sup>)<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR18">18</xref></sup>. Embryonic day (E) 9.5 <italic>Tg(Kat6b)</italic> embryos and E14.5 and E18.5, <italic>Tg(Kat6b)</italic> foetuses were present at expected Mendelian ratios (<italic>N</italic>&#x02009;=&#x02009;15, <italic>p</italic>&#x02009;=&#x02009;0.2; <italic>N</italic>&#x02009;=&#x02009;21, <italic>p</italic>&#x02009;=&#x02009;0.6; <italic>N</italic>&#x02009;=&#x02009;18, <italic>p</italic>&#x02009;=&#x02009;0.6; at E9.5, E14.5 and E18.5, respectively; binomial probability <italic>p</italic> values). <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup> foetuses were underrepresented at E18.5 (<italic>N</italic>&#x02009;=&#x02009;16, <italic>p</italic>&#x02009;=&#x02009;0.8; <italic>N</italic>&#x02009;=&#x02009;6, <italic>p</italic>&#x02009;=&#x02009;0.1; <italic>N</italic>&#x02009;=&#x02009;4, <italic>p</italic>&#x02009;=&#x02009;0.02; at E9.5, E14.5 and E18.5, respectively). In contrast, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> foetuses that lacked <italic>Kat6a</italic>, but overexpressed <italic>Kat6b</italic>, were obtained at the expected Mendelian ratio (<italic>N</italic>&#x02009;=&#x02009;9, <italic>p</italic>&#x02009;=&#x02009;1.0; <italic>N</italic>&#x02009;=&#x02009;8, <italic>p</italic>&#x02009;=&#x02009;1.0; <italic>N</italic>&#x02009;=&#x02009;10, <italic>p</italic>&#x02009;=&#x02009;1.0; at E9.5, E14.5 and E18.5, respectively).</p></sec><sec id="Sec4"><title><italic>Kat6b</italic> overexpression restored histone acetylation and cell proliferation in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> fibroblasts and histone acetylation in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> embryos</title><p id="Par13">To determine whether KAT6B was capable of compensating for the loss of KAT6A at the biochemical level, histone acetylation levels at previously identified KAT6A lysine targets, H3K9 and H3K23, as well as H3K14, were assessed chromatin-wide by Western blotting in primary mouse embryonic fibroblasts (MEFs) and in whole embryonic day 9.5 (E9.5) embryos.</p><p id="Par14"><italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup> MEFs had a 40% reduction in acetylation at H3K23 (H3K23ac), relative to wild type controls (<italic>p</italic>&#x02009;=&#x02009;0.03; Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1c, d</xref>). Overexpression of <italic>Kat6b</italic> in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> MEFs returned H3K23ac levels to wild-type levels (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1c, d</xref>). H3K23ac was similar in <italic>Kat6b</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> and wild-type <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> control MEFs (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1c, d</xref>). Chromatin-wide H3K9 and H3K14 acetylation levels were not affected by KAT6A or KAT6B status in this cell type (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2a</xref>&#x02013;<xref rid="MOESM1" ref-type="media">d</xref>).</p><p id="Par15">Consistent with previous reports<sup><xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR47">47</xref>,<xref ref-type="bibr" rid="CR48">48</xref></sup>, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> MEFs underwent cell cycle arrest after only 3 passages in culture (<italic>p</italic>&#x02009;=&#x02009;0.00007; Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1e, f</xref>). Overexpression of <italic>Kat6b</italic> restored cell proliferation in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> MEFs compared to <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> cells to levels similar to wild-type <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> control MEFs (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1e, f</xref>).</p><p id="Par16">In E9.5 <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos, acetylation levels at H3K9 (<italic>p</italic>&#x02009;=&#x02009;0.046; Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1g, h</xref>) and H3K23 (<italic>p</italic>&#x02009;=&#x02009;0.02; Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1i, j</xref>) were 32% and 43% reduced, respectively, compared to <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> control embryos. Overexpression of <italic>Kat6b</italic> returned the histone acetylation levels to normal in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> embryos compared to <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> control embryos (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1c, d, g&#x02013;j</xref>). Interestingly, H3K9 and H3K23 were elevated by 41% and 39%, respectively, in <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> samples compared to controls (<italic>p</italic>&#x02009;=&#x02009;0.01&#x02013;0.03); (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1g&#x02013;j</xref>). H3K14ac was not affected by KAT6A or KAT6B status in E9.5 embryos (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2e, f</xref>). Representative images of E9.5 embryos are shown in (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1k</xref>).</p></sec><sec id="Sec5"><title><italic>Kat6b</italic> overexpression reversed most gene expression changes present in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup> E9.5 embryos</title><p id="Par17">Loss of KAT6A has previously been shown to reduce expression of gene families encoding embryonic patterning transcription factors, most notably <italic>Hox</italic> genes<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, <italic>Tbx</italic> genes<sup><xref ref-type="bibr" rid="CR18">18</xref></sup> and <italic>Dlx</italic> genes<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>. To determine how mRNA levels affected by loss of KAT6A were altered when KAT6B was overexpressed, we performed RNA-sequencing of <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> and <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> E9.5 embryos (Supplementary Data&#x000a0;<xref rid="MOESM4" ref-type="media">2</xref>&#x02013;<xref rid="MOESM7" ref-type="media">5</xref>). E9.5 was chosen as a timepoint when major patterning genes previously shown to be perturbed by loss of KAT6A are highly expressed.</p><p id="Par18">Samples clustered within genotype and segregated between genotypes (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2a</xref>). Interestingly, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> RNA profiles were more closely related to wild-type control profiles in dimension 1, as assessed by multidimensional scaling, compared to <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> profiles, but segregated from the other genotypes in dimension 2, indicating that, despite more closely resembling wild-type controls than <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>samples, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> samples still maintained distinct RNA expression profiles.<fig id="Fig2"><label>Fig. 2</label><caption><title><italic>Kat6b</italic> overexpression reverses gene expression changes present in <italic>Kat6a</italic><sup>&#x02013;/&#x02013;</sup> E9.5 embryos.</title><p><bold>a</bold>&#x02013;<bold>i</bold> RNA-sequencing data of <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> and <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b</italic>) E9.5 embryos. <italic>N</italic>&#x02009;=&#x02009;4 embryos per genotype. Data were analysed as described in the &#x02018;methods&#x02019; section. A false discovery (FDR)&#x02009;&#x0003c;&#x02009;0.05 was used as the cut off for significance. <bold>a</bold> Multidimensional scaling plot of the leading gene expression differences between samples in pair-wise comparisons showing <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> and <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b</italic>) E9.5 embryo RNA samples. <bold>b</bold> M (log ratio) and A (mean average) plot showing <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> and <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos. The total numbers of upregulated and downregulated genes at FDR&#x02009;&#x0003c;&#x02009;0.05 are indicated in each comparison. Upregulated genes are represented in red, downregulated in blue and unchanged genes in grey. <bold>c</bold> Heatmap showing genes differentially expressed in the contrast of <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos but displayed for all genotypes. <bold>d</bold> Venn diagram showing the intersection of genes downregulated (DR) in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup>
<italic>Kat6b</italic><sup><italic>+/+</italic></sup> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos with those downregulated in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> samples vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos compared to those upregulated in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> samples vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos. <bold>e</bold> Top 20 gene ontology (GO) (BP) terms downregulated in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos and rescued in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> when compared to <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos. GO terms enriched with <italic>p</italic>&#x02009;&#x0003c;&#x02009;10<sup>&#x02013;6</sup> are shown. <bold>f</bold> Top 20 gene ontology (GO) (BP) terms upregulated in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos and rescued in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> when compared to <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos. GO terms enriched with <italic>p</italic>&#x02009;&#x0003c;&#x02009;10<sup>&#x02013;6</sup> are shown. <bold>g</bold>&#x02013;<bold>i</bold> Specific gene families previously reported to be affected by loss of KAT6A<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR44">44</xref></sup> were examined. Correction for multiple testing was conducted within gene family. FDRs for each comparison are shown above each bar. <bold>g</bold>&#x02013;<bold>i</bold> Log<sub>2</sub> fold-change in levels of HOX gene mRNA (<bold>g</bold>), DLX gene mRNA (<bold>h</bold>) and TBX gene mRNA (<bold>i</bold>) across pairwise comparisons <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos and <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> vs. <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos. FDRs are displayed above or below the bars.</p></caption><graphic xlink:href="41467_2025_57155_Fig2_HTML" id="d33e1896"/></fig></p><p id="Par19">A total of 482 genes were differentially expressed in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> E9.5 embryos with transcriptome-wide significance (FDR&#x02009;&#x0003c;&#x02009;0.05); 245 genes were downregulated, and 237 genes were upregulated (Supplementary Data&#x000a0;<xref rid="MOESM4" ref-type="media">2</xref>). Overexpression of <italic>Kat6b</italic> in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> embryos reduced the number of differentially expressed genes compared to <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos to 285 genes, 165 downregulated and 120 upregulated (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2b</xref>; Supplementary Data&#x000a0;<xref rid="MOESM5" ref-type="media">3</xref>). Other pairwise comparisons are shown in Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">3a</xref> and Supplementary Data&#x000a0;<xref rid="MOESM6" ref-type="media">4</xref>&#x02013;<xref rid="MOESM9" ref-type="media">7</xref>. A heat map shows that <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> embryos clustered more closely with wild-type <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>control embryos than <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>samples (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2c</xref>).</p><p id="Par20">Of the 245 genes downregulated in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, only 28 genes were similarly downregulated in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> samples (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2d</xref>; Supplementary Data&#x000a0;<xref rid="MOESM4" ref-type="media">2</xref> and <xref rid="MOESM5" ref-type="media">3</xref>), while two of the rescued genes, (<italic>Cdx2, Hoxa10</italic>), were overcompensated, i.e., expressed at higher levels in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> E9.5 embryos.</p><p id="Par21">The genes downregulated in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> E9.5 embryos were enriched in gene ontology (BP) terms relating to embryonic development, embryo patterning and DNA binding transcription factors regulating these processes (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">3b</xref>). The genes that displayed a rescue of mRNA levels from downregulated in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> E9.5 embryos to normal levels in <italic>Kat6b</italic> in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> E9.5 embryos were enriched for similar developmental processes (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2e, f</xref>). Genes upregulated in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> E9.5 embryos showed no specificity to embryonic development (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">3c</xref>).</p><p id="Par22">Among the rescued genes were the major families of embryonic patterning genes previously reported as downregulated in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup> embryos; <italic>Hox</italic> genes<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, <italic>Tbx</italic> genes<sup><xref ref-type="bibr" rid="CR18">18</xref></sup> and <italic>Dlx</italic> genes<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>. The major downregulation of <italic>Hox</italic> genes observed in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> E9.5 embryos (FDR&#x02009;&#x0003c;&#x02009;10<sup>&#x02212;6</sup> to 0.03 within gene family; Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">3d, e</xref>; Data&#x000a0;<xref rid="MOESM10" ref-type="media">8</xref>) was no longer present in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> E9.5 embryos (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2g</xref>), indicating that KAT6B can promote expression of <italic>Hox</italic> genes in the absence of KAT6A. Only <italic>Hoxb3</italic> mRNA levels were not fully returned to wild-type levels, but still were significantly elevated in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> vs. <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos (FDR&#x02009;=&#x02009;10<sup>&#x02212;5</sup>; Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2g</xref>), indicating a partial rescue. Similarly, <italic>Dlx</italic> genes downregulated in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos (FDR&#x02009;=&#x02009;6&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup> to 0.004 within gene family; Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">3d, e</xref>, Data&#x000a0;<xref rid="MOESM10" ref-type="media">8</xref>) were no longer downregulated in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> (FDR&#x02009;=&#x02009;0.2 to 1; Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2h</xref>). <italic>Tbx</italic> genes were downregulated <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos (FDR&#x02009;&#x0003c;&#x02009;10<sup>&#x02212;6</sup> to 0.04 within gene family; Supplementary Data&#x000a0;<xref rid="MOESM10" ref-type="media">8</xref>) and were upregulated in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> vs. <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, except <italic>Tbx15</italic> (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2i</xref>; Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">3d, e</xref>, Supplementary Data&#x000a0;<xref rid="MOESM10" ref-type="media">8</xref>). This upregulation returned <italic>Tbx2, Tbx3 and Tbx5</italic> mRNA levels in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> embryos to comparable levels to <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos (FDR&#x02009;=&#x02009;0.06 to 0.3). The mRNA levels of <italic>Tbx1</italic> were significantly elevated in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> embryos above <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos (FDR&#x02009;=&#x02009;0.0006), but still lower than in <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos (FDR&#x02009;=&#x02009;0.006), indicating a partial rescue. Overall, 217 (89%) of 245 genes downregulated and 222 (94%) of the 237 upregulated genes in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> E9.5 embryos were rescued by overexpression of <italic>Kat6b</italic> in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos, indicating that KAT6B overexpression substantially restores expression of genes, which were reduced in the absence of KAT6A (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2d</xref>; Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">4a, b</xref>). Examining the gene expression not rescued in more detail we found the majority of these 28 downregulated and 15 upregulated genes showed relatively small differential gene expression changes, less than 2-fold, (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">4c, d</xref>), which were associated with GO terms relating to transcription in the case of downregulated genes and cell adhesion in the case of upregulated genes (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">4e, f</xref>). Some 236 genes were uniquely differentially expressed in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">4g&#x02013;i</xref>) and a comparatively small number of genes (75) were differentially expressed when embryos overexpressing <italic>Kat6b</italic> were compared to wild type (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">4j&#x02013;l</xref>).</p></sec><sec id="Sec6"><title><italic>Kat6b</italic> overexpression restored transplantable haematopoietic stem cells that are absent in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup> mice</title><p id="Par23">KAT6A is essential for development of HSCs. Germline deletion of the <italic>Kat6a</italic> gene results in a complete failure to form definitive HSCs during foetal development<sup><xref ref-type="bibr" rid="CR42">42</xref>,<xref ref-type="bibr" rid="CR43">43</xref></sup>, and deletion of <italic>Kat6a</italic> in adult HSCs causes their complete loss<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>.</p><p id="Par24">The numbers of HSCs in <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic>, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> and <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> foetal livers were assessed by flow cytometry (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a, b</xref>). Analysis was performed at E14.5, at the peak of foetal haematopoiesis in mice<sup><xref ref-type="bibr" rid="CR50">50</xref>,<xref ref-type="bibr" rid="CR51">51</xref></sup> and HSCs were identified as CD48<sup>&#x02013;</sup> CD150<sup>+</sup>, as described<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>. As previously described<sup><xref ref-type="bibr" rid="CR42">42</xref>,<xref ref-type="bibr" rid="CR43">43</xref></sup>, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> foetal livers showed a 95% reduction in cells with an HSC cell surface phenotype compared to wild-type <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> control foetal livers (<italic>p</italic>&#x02009;=&#x02009;0.00007; Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3b</xref>). Overexpression of <italic>Kat6b</italic> in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> foetuses elevated the number of HSC 11.5-fold, compared to <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> foetuses (<italic>p</italic>&#x02009;=&#x02009;0.01; Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3b</xref>), however, HSCs were still reduced in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> foetuses compared to <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> control foetuses (<italic>p</italic>&#x02009;=&#x02009;0.04; Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3b</xref>). Consistently, expression of the haematopoietic marker gene <italic>Kit</italic><sup><xref ref-type="bibr" rid="CR50">50</xref>,<xref ref-type="bibr" rid="CR53">53</xref></sup> was downregulated in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> E9.5 embryos (FDR&#x02009;=&#x02009;0.007; Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3c</xref>), rescued in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> vs. wild-type embryos (FDR&#x02009;=&#x02009;0.2) and upregulated in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> vs. <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos (FDR&#x02009;=&#x02009;6&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;5</sup>; Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3c</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><title><italic>Kat6b</italic> overexpression restores transplantable haematopoietic stem cells that are absent in <italic>Kat6a</italic><sup>&#x02013;/&#x02013;</sup> mice.</title><p><bold>a</bold> Flow cytometry gating strategy for the assessment of haematopoietic stem cells (HSCs) in E14.5 foetal livers. HSCs were identified as the CD48<sup>&#x02013;</sup>CD150<sup>+</sup> cell population within the lineage marker negative (LIN<sup>&#x02013;</sup>) cKIT and SCA1 positive cell population (LSK; gated on single, viable cells, lacking expression of lineage (LIN) markers B220, CD19, CD4, CD8, GR1 and TER119 and expressing SCA1 and cKIT). Representative plots for HSCs are shown for each genotype. <bold>b</bold> Total number of HSCs per foetal liver of <italic>N</italic>&#x02009;=&#x02009;3 <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>N</italic>&#x02009;=&#x02009;8 <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>N</italic>&#x02009;=&#x02009;6 <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> and <italic>N</italic>&#x02009;=&#x02009;4 <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> foetuses. <bold>c</bold> Log<sub>2</sub> fold-change in <italic>Kit</italic> mRNA levels in E9.5 embryos as assessed by RNA-sequencing across the comparisons <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> vs. <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> and <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> vs. <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos. <italic>N</italic>&#x02009;=&#x02009;4 embryos per genotype. The FDRs are shown above the bars. Data were analysed as described in the &#x02018;methods&#x02019; section under <italic>RNA sequencing and analysis</italic>. <bold>d</bold> Percentage survival of irradiated recipient mice after transplantation of 1&#x02009;&#x000d7;&#x02009;10<sup>6</sup> foetal liver cells from <italic>N</italic>&#x02009;=&#x02009;3 <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>N</italic>&#x02009;=&#x02009;4 <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic>, <italic>N</italic>&#x02009;=&#x02009;3 <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>TgKat6b)</italic> or <italic>N</italic>&#x02009;=&#x02009;5 <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> E14.5 mouse foetuses; each foetal liver sample was transplanted into 3 lethally irradiated recipients. Data are displayed in a Kaplan-Meier plot and were analysed using a Mantel-Cox test. <bold>e</bold> Automated haematological analyser (ADVIA) assessment of red blood cells per &#x003bc;l peripheral blood in recipient mice of E14.5 foetal liver donor cells from <italic>N</italic>&#x02009;=&#x02009;5 <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>N</italic>&#x02009;=&#x02009;3 <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic>, <italic>N</italic>&#x02009;=&#x02009;4 <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> or <italic>N</italic>&#x02009;=&#x02009;3 <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> foetuses, at a time 3&#x02013;4 weeks after transplantation when the recipient mice of <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> donor cells in each set reached the ethical end-point. Each foetal liver sample was transplanted into 3 recipient mice. Each circle represents the average of the recipient mice of an individual foetal liver donor. Data are displayed as mean&#x02009;&#x000b1;&#x02009;s.e.m. and were analysed using a one-way ANOVA with Dunnett post-hoc correction. <bold>f</bold> Gating strategy for the assessment of peripheral blood of foetal liver transplant recipient mice. B cells were defined as B220<sup>+</sup>CD19<sup>+</sup>, T cells as CD4<sup>+</sup> or CD8<sup>+</sup>, granulocytes as GR1<sup>hi</sup> MAC1<sup>+</sup> and monocytes as GR1<sup>lo</sup>MAC1<sup>+</sup>. Foetal liver donor-derived cells (CD45.1<sup>+</sup>) were distinguished from residual recipient cells (CD45.1/2<sup>+</sup>). <bold>g</bold>, <bold>h</bold> Contribution of foetal liver (donor)-derived cells to peripheral blood populations at 4 weeks (<bold>f</bold>) and 20 weeks (<bold>g</bold>) post transplantation of the recipients described in (<bold>e</bold>). <bold>i</bold> Gating strategy for the assessment of stem and progenitor cells in the bone marrow of foetal liver transplant recipient mice. Cell types as indicated on the plots were distinguished by CD48 vs. CD150, CD34 vs. CD16.32 or IL7R&#x003b1; expression. (j&#x02013;k) Contribution of foetal liver (donor)-derived cells to stem and progenitor populations in the bone marrow of foetal liver cell recipients at 20 weeks post-transplantation in CD48 vs. CD150 (<bold>i</bold>), CD34 vs CD16/32 (<bold>j</bold>) cell populations. <bold>l</bold> Gating strategy for the assessment of B cell progenitors in the bone marrow of foetal liver transplant recipient mice. Cells were gated on single, viable cells co-expressing B220 and CD19 and distinguished by cKIT, IgM and IgD expression to identify the cell populations indicated in the plots. <bold>m</bold> Contribution of foetal liver (donor)-derived cells to bone marrow B cell progenitors 20 weeks post-transplant. Circles represent individual foetuses (<bold>b</bold>) or the mean of three recipients of a single foetal liver donor (<bold>g</bold>, <bold>h</bold>, <bold>j</bold>, <bold>k</bold>, <bold>m</bold>). Data are presented as mean&#x02009;&#x000b1;&#x02009;s.e.m. and were analysed using a one-way ANOVA (<bold>b</bold>) or two-way ANOVA with Tukey post hoc correction (<bold>g</bold>, <bold>h</bold>, <bold>j</bold>, <bold>k</bold>, <bold>m</bold>). HSCs, haematopoietic stem cells; LK; lineage marker negative cKIT<sup>+</sup> cells; LSK, lineage marker negative SCA1<sup>+</sup>cKIT<sup>+</sup> cells; HPC-1 (haematopoietic progenitor 1), HPC-2 (haematopoietic progenitor 2), MPP (multipotent progenitor), CLP (common lymphoid progenitor), CMP (common myeloid progenitor), GMP (granulocyte macrophage progenitors), MEP (megakaryocyte/erythroid progenitor). Granulo (granulocytes), Mono (monocytes); superscript: int, intermediate.</p></caption><graphic xlink:href="41467_2025_57155_Fig3_HTML" id="d33e3190"/></fig></p><p id="Par25">To assess the effect of KAT6B overexpression on the function of HSCs lacking KAT6A, 1&#x02009;&#x000d7;&#x02009;10<sup>6</sup> foetal liver cells were transplanted into irradiated recipients, as previously described<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. Recipients of <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> foetal liver cells reached the ethical endpoint within 21 days (<italic>p</italic>&#x02009;&#x0003c;&#x02009;10<sup>&#x02013;6</sup>; Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3d</xref>), exhibiting anaemia (<italic>p</italic>&#x02009;=&#x02009;10<sup>&#x02013;6</sup>; Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3e</xref>) and minimal contribution of the foetal liver donor cells to the recipient peripheral blood (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">5a</xref>). In contrast, recipients of <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> cells survived beyond 150 days, as did recipients of wild type or <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> cells (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3d</xref>). At 4 weeks post-transplantation, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> donor cell contribution to peripheral blood cells was similar to <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> donor cells, except for a reduction in CD8 T cells (<italic>p</italic>&#x02009;=&#x02009;0.03; Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3f, g</xref>). At 20 weeks post-transplantation, contribution to all peripheral cell types was identical between <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> and <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> donor cells (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3h</xref>). Interestingly, compared to wild type controls, <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> donor cells showed an elevated contribution to CD8 T cells at 4 weeks, (<italic>p</italic>&#x02009;&#x0003c;&#x02009;10<sup>&#x02013;6</sup>; Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3g</xref>) and 20 weeks (<italic>p</italic>&#x02009;=&#x02009;0.00005; Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3h</xref>), with a reduced contribution to CD4 T cells at 20 weeks (<italic>p</italic>&#x02009;&#x0003c;&#x02009;10<sup>&#x02013;6</sup>; Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3h</xref>). In the bone marrow at 20 weeks post-transplantation, recipients of <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic>, <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> and <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> donor cells showed comparable contributions to all stem and progenitor cell populations, except for a small reduction (less than 10%) in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> contribution to the B220<sup>+</sup>CD19<sup>+</sup>, ProB and PreB cell populations (<italic>p</italic>&#x02009;&#x0003c;&#x02009;10<sup>&#x02013;6</sup> to 0.002; Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3i&#x02013;m</xref>). No difference was observed between recipients of <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> and <italic>Kat6b</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> recipients across bone marrow populations analysed (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3i&#x02013;m</xref>).</p></sec><sec id="Sec7"><title><italic>Kat6b</italic> overexpression rescued the anterior homeotic transformation seen in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup> mice</title><p id="Par26">Germline deletion of the <italic>Kat6a</italic> gene results in duplication of the first cervical vertebra, the atlas, accompanied by an extensive and complete homeotic transformation of 19 body segments. This anterior homeotic transformation is caused by a posterior shift of the anterior expression boundary and expression levels of <italic>Hox</italic> genes, including <italic>Hoxa3, Hoxa4, Hoxb3</italic> and <italic>Hoxb4</italic><sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. Consistent with this previous work<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> and the reduced <italic>Hox</italic> gene expression in E9.5 embryos shown here (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2g</xref>), <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> pups displayed an anterior homeotic transformation at E18.5 (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4a</xref>; Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">6</xref>). In addition, we saw disrupted sternum sections, sternebrae and incorrect alignment of ribs at the sternum in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> pups (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4b</xref>). Congruent with a rescue of the <italic>Hox</italic> gene expression profile at E9.5 (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2g</xref>), the vertebral segment identity, sternebrae structure and rib attachment were rescued in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> pups at E18.5 (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4a, b</xref>). The cervical vertebrae, sternebrae and rib attachment were normal in <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> and <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> pups (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5a, b</xref>). No obvious effects of KAT6A or KAT6B genotype was observed on lumbar and sacral elements (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">7</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><title><italic>Kat6b</italic> overexpression rescues the anterior homeotic transformation seen in <italic>Kat6a</italic><sup>&#x02013;/&#x02013;</sup> mice.</title><p><bold>a</bold>, <bold>b</bold> Alizarin red (bone) and Alcian blue (cartilage) stained skeletal preparations of <italic>N</italic>&#x02009;=&#x02009;9 <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, 1 <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, 4 <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> and 5 <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> E18.5 foetuses with labelled cervical vertebrae (<bold>a</bold>) and sternum (<bold>b</bold>), arrow indicates abnormal rib attachment (<bold>b</bold>). Note that embryos homozygous for this allele of&#x000a0;<italic>Kat6a</italic> rarely survive until E18.5. Representative images are shown. Representative images of RNA/RNA whole-mount situ hybridisation to detect <italic>Hoxa5</italic> (<bold>c</bold>) and <italic>Hoxc5</italic> (<bold>d</bold>) mRNA in <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup><italic>, Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup><italic>, Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> and <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> E10.5 embryos, with anterior expression boundary indicated. Note no staining using the sense control probe (<italic>n</italic>&#x02009;=&#x02009;3 wild type embryos). The 3&#x02013;4 most cranial somites are indicated by a dot (<bold>c</bold>, <bold>d</bold>). The anterior expression boundary of <italic>Hoxa5</italic> is indicated by a stippled line (<bold>c</bold>). The distance between the anterior boundary of the <italic>Hoxc5</italic> expression domain in the neural tube and the caudal boundary of the otic vesicle is indicated by a bracket (<bold>d</bold>). The distance was measured and is displayed in the bar graph in (<bold>d</bold>). <italic>Hoxa5</italic>
<italic>N</italic>&#x02009;=&#x02009;3, <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>N</italic>&#x02009;=&#x02009;3, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>N</italic>&#x02009;=&#x02009;3, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> and <italic>N</italic>&#x02009;=&#x02009;3, <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> were used. <italic>Hoxc5</italic>
<italic>N</italic>&#x02009;=&#x02009;4, <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>N</italic>&#x02009;=&#x02009;4, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>N</italic>&#x02009;=&#x02009;4, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> and <italic>N</italic>&#x02009;=&#x02009;4, <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> were used. This experiment was repeated a second time with each probe with <italic>N</italic>&#x02009;=&#x02009;3 embryos per genotype. Data are presented as means&#x02009;&#x000b1;&#x02009;s.e.m. and were analysed by one-way ANOVA with Tukey&#x02019;s multiple comparison test. Circles in the bar graph (<bold>d</bold>) represent individual embryos. 1b, mandibular region of the first pharyngeal arch; 2, second pharyngeal arch; At, atlas&#x02009;=&#x02009;1st cervical vertebra, C1; Ax, axis&#x02009;=&#x02009;2nd cervical vertebra, C2; C1 to C7, 1st to 7th cervical vertebrae; C1&#x02019; to C8&#x02019;, 1st to 8th abnormal <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> cervical vertebrae, whereby C8&#x02019; is supernumerary; E eye, FB forebrain, FL forelimb, HB hindbrain, He heart, HL hindlimb, M manubrium, MB midbrain, o otic vesicle, S sternebrae, T1 1st thoracic vertebra (rib bearing). Xp xiphoid process, Xs xiphisternum. Scale bar&#x02009;=&#x02009;1&#x02009;mm (<bold>a</bold>, <bold>b</bold>), 600&#x02009;&#x000b5;m (<bold>c</bold>), 680&#x02009;&#x000b5;m (<bold>d</bold>).</p></caption><graphic xlink:href="41467_2025_57155_Fig4_HTML" id="d33e3810"/></fig><fig id="Fig5"><label>Fig. 5</label><caption><title>Kat6b overexpression rescues the cleft palate, aortic arch and cardiac defects observed in <italic>Kat6a</italic><sup>&#x02013;/&#x02013;</sup> mice.</title><p><bold>a</bold>&#x02013;<bold>e</bold> Examination of <italic>N</italic>&#x02009;=&#x02009;7 <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>N</italic>&#x02009;=&#x02009;1 <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, <italic>N</italic>&#x02009;=&#x02009;5 <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> and <italic>N</italic>&#x02009;=&#x02009;6 <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> foetuses at E18.5 during dissection and by histopathology. Note that embryos homozygous for this allele of KAT6a rarely survive until E18.5. <bold>a</bold> Lateral view of the head and neck of E18.5 <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup><italic>, Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup><italic>, Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> and <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> foetuses. The arrow indicates an underdeveloped lower jaw in the <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> mouse. <bold>b</bold> Ventral view of the palate of E18.5 <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup><italic>, Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup><italic>, Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> and <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> foetuses. The arrow indicates a cleft palate in the <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> mouse. <bold>c</bold>, <bold>d</bold> Images of the heart and aortic arch of <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup><italic>, Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup><italic>, Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> and <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> E18.5 foetuses (<bold>c</bold>). Traces of the aortic arch and arteries (<bold>d</bold>). <bold>e</bold> H&#x00026;E sections of the hearts of <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup><italic>, Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup><italic>, Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> and <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> E18.5 foetuses. Arrowhead indicates the ventricular septal defect in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> animals. AA aortic arch, LA left atrium, LCCA left common carotid artery, LSA left subclavian artery, LV left ventricle, P2 secondary palate, PP primary palate, RA right atrium, RCCA right common carotid artery, RSA right subclavian artery, RV right ventricle, VS ventricular septum. Scale bars are 2&#x02009;mm (<bold>a</bold>), 1&#x02009;mm (<bold>b</bold>, <bold>c</bold>), 500&#x02009;&#x003bc;m (<bold>e</bold>).</p></caption><graphic xlink:href="41467_2025_57155_Fig5_HTML" id="d33e4101"/></fig></p><p id="Par27">To examine the pattern of <italic>Hox</italic> gene expression more closely we performed whole mount in situ hybridisation. We have previously shown that not only is <italic>Hox</italic> gene expression down regulated in embryos but also that the anterior boundary is shifted posteriorly, which leads to an anterior homeotic transformation<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. We examined the expression patterns of <italic>Hoxa3</italic>, <italic>Hoxa5</italic> and <italic>Hoxc5</italic>, as we have previously shown that the expression of these genes most clearly demonstrates the effect of <italic>Kat6a</italic> loss on the anterior boundary of <italic>Hox</italic> gene expression<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR54">54</xref></sup>. As previously reported, the <italic>Hoxa5</italic> and <italic>Hoxc5</italic> expression is shifted posteriorly and expressed at lower levels in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4c, d</xref>; Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">7</xref>). The anterior boundary and level of expression of both <italic>Hoxa5</italic> and <italic>Hoxc5</italic> in rescued in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> embryos to the wild type position. Interestingly, the anterior boundary of <italic>Hoxa5</italic> expression in <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> embryos is not different to wild type littermate embryos. Similarly, <italic>Hoxa3</italic> expression, reduced and posteriorly shifted in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos, is restored in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> embryos to the wild type pattern of expression (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">7</xref>).</p></sec><sec id="Sec8"><title><italic>Kat6b</italic> overexpression rescued the cleft palate, cardiac and aortic arch defects observed in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup> mice</title><p id="Par28"><italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup> mice have previously been shown to have cleft palate<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR44">44</xref></sup>, ventricular septum defects<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR45">45</xref></sup> and aortic arch defects<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. Congruent with these previous studies, cleft palate (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5a, b</xref>), aortic arch defects (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5c, d</xref>) and ventricular septal defects (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5e</xref>) were observed in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> mice (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5a&#x02013;e</xref>). Overexpression of <italic>Kat6b</italic> in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> mice rescued each of these major phenotypic anomalies (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5a&#x02013;e</xref>).</p></sec><sec id="Sec9"><title><italic>Kat6b</italic> overexpression rescued the pattern of H3K23 acetylation at <italic>Kat6a</italic> target loci</title><p id="Par29">Western blot analysis showed that loss of KAT6A function results in a global reduction in H3K23ac in E9.5 embryos and MEFs, and that this is restored in the <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> condition. To examine specific genomic loci in more detail, in particular <italic>Hox</italic> clusters, <italic>Tbx</italic> and <italic>Dlx</italic> genes, we performed Cleavage Under Targets and Tagmentation (CUT&#x00026;Tag) sequencing for H3K23ac. Since H3K23ac is one of the most abundant histone acetylation modifications and is widespread throughout the genome we used a <italic>Drosophila</italic> spike-in control to allow direct comparison between samples. Across samples H3K23ac showed a characteristic peak at the transcription start site (TSS) and a large difference between <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup> vs. <italic>Kat6b</italic><sup><italic>+/+</italic></sup> in a multidimensional scaling plot (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">8a&#x02013;c</xref>; Data&#x000a0;<xref rid="MOESM11" ref-type="media">9</xref>). As expected, H3K23ac levels were reduced across the genome at 16889 loci in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup> samples compared to wild type controls (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6a</xref>; Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">8d</xref>). This reduction in H3K23ac was completely reversed in cells prepared from <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> embryos (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6a</xref>; Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">8e&#x02013;g</xref>; Data&#x000a0;<xref rid="MOESM12" ref-type="media">10</xref>&#x02013;<xref rid="MOESM14" ref-type="media">12</xref>). Specifically examining all <italic>Hox</italic> genes we found that H3K23ac was reduced in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup> cells compared to wild type and normal levels were restored in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> cells (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6b</xref>). Similarly at both <italic>Tbx</italic> and <italic>Dlx</italic> genes, H3K23ac was reduced in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup> cells and restored in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> cells (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6c, d</xref>). Mapping individual reads across <italic>Hox</italic>, <italic>Tbx</italic> and <italic>Dlx</italic> loci (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6e&#x02013;g</xref>) showed that H3K23ac was distributed across the gene body with distinctive peaks at promoters and other genomic features (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">8c</xref>). Unfortunately, we were unable to correlate the distribution of KAT6A or KAT6B with H3K23ac peaks as no CUT&#x00026;Tag capable antibodies with the necessary specificity are available. The wild type pattern of peaks was faithfully reproduced in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> cells (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6e&#x02013;g</xref>).<fig id="Fig6"><label>Fig. 6</label><caption><title>Decrease in H3K23ac in <italic>Kat6a</italic><sup>&#x02013;/&#x02013;</sup> cells restored to normal in <italic>Kat6a</italic><sup>&#x02013;/&#x02013;</sup><italic>Tg(Kat6b)</italic> cells.</title><p><bold>a</bold>&#x02013;<bold>g</bold> CUT&#x00026;Tag results detecting histone H3 lysine 23 acetylation in (H3K23ac) in primary mouse embryonic fibroblasts isolated from E14.5 <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup><italic>, Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup><italic>, Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> and <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> E10.5 foetuses. <italic>N</italic>&#x02009;=&#x02009;4 foetuses per genotype. Data were analysed as described in the &#x02018;methods&#x02019; section. A false discovery rate (FDR) of less than 0.05 was considered significant. <bold>a</bold> Venn diagram showing number of genes with reduced H3K23ac levels in the indicated samples compared to wild type controls. In comparison to wild type cells <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup> cells show a global reduction in H3K23ac which is restored to normal in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> cells. <bold>b</bold>&#x02013;<bold>d</bold> Log<sub>2</sub> fold changes in H3K23ac levels at HOX genes (<bold>b</bold>), TBX genes (<bold>c</bold>) and DLX genes (<bold>e</bold>). Note that the reduction in H3K23ac in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup> MEFs is restored to normal in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> MEFs. The FDR is indicated above or below each bar. <bold>e</bold>&#x02013;<bold>g</bold> Read depth plots of H3K23ac in the HOXA gene cluster (<bold>e</bold>), at the <italic>Dlx1/Dlx2</italic> locus (<bold>f</bold>) and at the <italic>Tbx3/Tbx5</italic> locus. Note that the characteristic distribution of H3K23ac in wild type cells is restored in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> cells.</p></caption><graphic xlink:href="41467_2025_57155_Fig6_HTML" id="d33e4587"/></fig></p></sec><sec id="Sec10"><title><italic>Kat6b</italic> overexpression rescued the lethality of <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup> mice</title><p id="Par30">Overexpression of KAT6B rescued histone acetylation, gene expression patterns, transplantable HSCs, segment identity defects, heart and aortic arch defects and cleft palate previously described in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> mice. This demonstrates a complete rescue of all previously described developmental anomalies resulting from loss of KAT6A, including those that were incompatible with survival. To assess if perinatal lethality was rescued, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup>
<italic>Tg(Kat6b)</italic> mice were allowed to develop to birth and were monitored in early life.</p><p id="Par31"><italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>mice die between E14.5-E18.5 depending on the genetic background<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR18">18</xref></sup>. Overexpression of <italic>Kat6b</italic> completely rescued this foetal to perinatal lethality. <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> mice developed normally in the postnatal period, even compared to <italic>Kat6a</italic> heterozygous (<italic>Kat6a</italic><sup><italic>+/&#x02013;</italic></sup>) mice, which were notably runted in early life (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7a, b</xref>). Furthermore, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> mice showed normal weight gain over the first 3 weeks of life, compared to reduced weight gain observed in both male and female <italic>Kat6a</italic><sup><italic>+/&#x02013;</italic></sup> mice (<italic>p</italic>&#x02009;=&#x02009;0.001 and 1&#x02009;&#x000d7;&#x02009;10<sup>&#x02013;5</sup>; Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7b</xref>). Remarkably, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup>
<italic>Tg(Kat6b)</italic> mice of both sexes reached adulthood and were healthy and fertile. Among the offspring of <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> x <italic>Kat6a</italic><sup><italic>+/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> matings, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> mice were completely absent (<italic>N</italic>&#x02009;=&#x02009;0 of 94; <italic>p</italic>&#x02009;&#x0003c;&#x02009;10<sup>&#x02013;6</sup>; Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7c</xref>). In contrast, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> mice were present at the expected Mendelian ratio at weaning (<italic>N</italic>&#x02009;=&#x02009;32 of 94; <italic>p</italic>&#x02009;=&#x02009;1; Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7c</xref>). This demonstrates that KAT6B overexpression in the absence of KAT6A not only rescued the effects of the homozygous loss of <italic>Kat6a</italic>, but improved development in early life compared to <italic>Kat6a</italic> heterozygosity.<fig id="Fig7"><label>Fig. 7</label><caption><title><italic>Kat6b</italic> overexpression rescues the perinatal lethality of <italic>Kat6a</italic><sup>&#x02013;/&#x02013;</sup> mice.</title><p><bold>a</bold> Representative photographs of wild type, <italic>Kat6a</italic><sup><italic>+/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> and <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> mice at postnatal day 7 (left) and <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> and <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> mice at 12 weeks of age (right). <bold>b</bold> Weights of <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> (23 female; 16 male), <italic>Kat6a</italic><sup><italic>+/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> (16 female; 4 male), <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> (4 female; 4 male) and <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> (4 female; 4 male) mice from postnatal week 1 to week 12. Data presented as mean&#x02009;&#x000b1;&#x02009;s.e.m. and were analysed using a two-way ANOVA with Holm-Sidak post-hoc correction. <bold>c</bold> Genotypes at 3 weeks of age of offspring (<italic>N</italic>&#x02009;=&#x02009;94) of matings with the parental genotypes <italic>Kat6a</italic><sup><italic>+/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> x <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic>. The observed genotype frequency was compared to the expected Mendelian frequencies, <italic>p</italic> values of the binomial probability testing if a genotype was observed differed from the expected frequency are shown (two sided). <bold>d</bold>&#x02013;<bold>h</bold> Flow cytometry analysis of the bone marrow of <italic>N</italic>&#x02009;=&#x02009;4 adult <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup>, 5 <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> and 5 <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> mice. Flow cytometry gating strategies defining haematopoietic cell population using cell surface markers as described in Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>. Each circle represents an individual mouse. Data in (<bold>e</bold>, <bold>g</bold>, <bold>h</bold>) are presented as mean&#x02009;&#x000b1;&#x02009;s.e.m. Each circle represents an individual mouse. Data were analysed using a two-way ANOVA with Tukey post-hoc correction. Abbreviations as defined in Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>. Flow cytometry gating strategy (<bold>d</bold>) and analysis (<bold>e</bold>) of B cell progenitor populations in the bone marrow. Gating strategy (<bold>f</bold>) and analysis (<bold>g</bold>, <bold>h</bold>) of haematopoietic stem and progenitor population in the bone marrow.</p></caption><graphic xlink:href="41467_2025_57155_Fig7_HTML" id="d33e4962"/></fig></p><p id="Par32">Given the requirement for KAT6A in the adult haematopoietic system<sup><xref ref-type="bibr" rid="CR49">49</xref>,<xref ref-type="bibr" rid="CR55">55</xref></sup>, bone marrow stem and progenitor populations were assessed in adult <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> mice at 12 weeks of age. All stem and progenitor populations showed similar frequencies as in wild-type control mice (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7d&#x02013;h</xref>), indicating that haematopoietic development in adulthood is normal in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> animals.</p></sec></sec><sec id="Sec11" sec-type="discussion"><title>Discussion</title><p id="Par33">In this study we demonstrate that KAT6B, expressed at 4-fold above endogenous levels in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup> mice, rescues the previously described developmental defects resulting from homozygous loss of KAT6A. Remarkably, <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> mice are born, show normal development to adulthood and normal blood cell development in adulthood.</p><p id="Par34">In addition to rescuing the anatomical defects resulting from loss of KAT6A, KAT6B overexpression reverted ~90% of the changes in gene expression caused by loss of KAT6A and re-established global acetylation levels at H3K9 and H3K23 in whole E9.5 embryos and H3K23 in MEFs. Examining locus-specific acetylation we found complete restoration of the normal pattern of H3K23ac down to the level of individual peaks within transcription units. The rescue of genes downregulated in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> mice by KAT6B overexpression is particularly interesting, as KAT6B is not ordinarily required for expression of many KAT6A-dependent genes. In particular, while KAT6A is essential for the normal expression the <italic>Hox</italic>, gene families, KAT6B has no role in regulation of these genes and the axial skeleton develops normally without KAT6B. The capacity of overexpressed KAT6B to carry out the role of promoting their expression in the absence of KAT6A indicates that any target gene specificity of KAT6A arising from the differences in amino acid sequence between KAT6A and KAT6B, and perhaps affecting protein-protein interaction, can be overcome by higher levels of KAT6B.</p><p id="Par35"><italic>In utero</italic> treatment with retinoic acid, an activator of <italic>Hox</italic> gene expression<sup><xref ref-type="bibr" rid="CR56">56</xref>,<xref ref-type="bibr" rid="CR57">57</xref></sup>, rescues the anterior homeotic transformation in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup> mice, but not other developmental defects<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. Indeed, <italic>in utero</italic> retinoic acid treatment causes cardiac defects in <italic>Kat6a</italic><sup><italic>+/&#x02013;</italic></sup> mice<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. Conversely, the cardiac septum defect of <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup> mice was rescued by overexpressing the <italic>Tbx1</italic> gene<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. Body segment identity has been restored in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup> mice by additionally deleting <italic>Bmi1</italic><sup><xref ref-type="bibr" rid="CR54">54</xref></sup>. BMI1 is a polycomb repressor protein that represses <italic>Hox</italic> gene expression and, when deleted, causes a posterior homeotic transformation<sup><xref ref-type="bibr" rid="CR58">58</xref>,<xref ref-type="bibr" rid="CR59">59</xref></sup>. Combined deletion of <italic>Kat6a</italic> and <italic>Bmi1</italic> genes was found to restore the respective anterior and posterior homeotic transformations observed in single mutant mice<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>, but did not rescue the haematopoietic defects of <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup> mice<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>. Collectively, these results suggest that KAT6A does not act as a binary on-off switch, but rather the level of KAT6A activity acts to balance the activity of repressors to generate an appropriate level of gene expression in a cell-type specific context.</p><p id="Par36">Our data suggest that KAT6B overexpression in the absence of KAT6A may result in a more favourable stoichiometry of complex subunits to allow KAT6B to take on the role of KAT6A, compared to endogenous levels of KAT6B or KAT6B overexpression in the presence of KAT6A. In the absence of KAT6A, the limitation of auxiliary complex member availability may permit KAT6B, when overexpressed, to perform its own typical roles, as well as those of KAT6A, without spurious effects resulting from an overabundance of KAT6B. This is evident at the level of global histone acetylation, as acetylation levels at H3K9 and H3K23 in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> E9.5 embryos were similar to wild type controls, while these residues were hyperacetylated in <italic>Kat6a</italic><sup><italic>+/+</italic></sup><italic>Tg(Kat6b)</italic> samples.</p><p id="Par37">Notwithstanding the profound rescue of the expression levels of genes downregulated in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> embryos at E9.5 when <italic>Kat6b</italic> is overexpressed, some effects of the loss of KAT6A persisted. When only <italic>Tbx</italic> genes were considered (as opposed to transcriptome-wide analyses), <italic>Tbx1</italic> and <italic>15</italic> were still significantly downregulated in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> embryos compared to wild type control embryos. However, <italic>Tbx1</italic> was significantly increased in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Tg(Kat6b)</italic> embryos compared to <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> samples. This partial rescue was sufficient to rescue the cardiac defects of <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup><italic>Kat6b</italic><sup><italic>+/+</italic></sup> mice, consistent with the rescue of heart defects in <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup> mice by transgenic overexpression of <italic>Tbx1</italic><sup><xref ref-type="bibr" rid="CR18">18</xref></sup>.</p><p id="Par38">In addition to rescuing congenital defects resulting from loss of KAT6A, KAT6B overexpression restored the formation of definitive HSCs capable of reconstituting the haematopoietic system of irradiated recipient mice. Paralleling a previous report that loss of KAT6A reduces CD8 cell surface expression<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>, we found that KAT6B overexpression promoted CD8 T cell formation at the expense of CD4 T cell development in transplant recipient mice, and that this effect of overexpressed KAT6B was modulated by the loss of KAT6A.</p><p id="Par39">Recently, inhibitors have been developed for both CBP/p300<sup><xref ref-type="bibr" rid="CR61">61</xref></sup> and KAT6A/KAT6B<sup><xref ref-type="bibr" rid="CR30">30</xref></sup> protein pairs with the view of developing novel cancer therapeutics. Currently, the KAT6A/KAT6B inhibitors are in clinical trials for the treatment of solid cancers<sup><xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR62">62</xref></sup>. In the process of developing these inhibitors it has become clear that it would be unlikely that any inhibitor would differentially inhibit one and not the other of each of these protein pairs. It is therefore relevant to determine the functional equivalence of the proteins within pairs. The combined deletion of these proteins only reveals how similar their functions are at endogenous expression levels. In contrast, our data on the rescue of the <italic>Kat6a</italic><sup><italic>&#x02013;/&#x02013;</italic></sup> mice by overexpression of KAT6B indicate that KAT6B can replace KAT6A so completely that it can rescue the 100% lethality, producing healthy and fertile mice that lack KAT6A. These results suggest that simultaneous inhibition of both KAT6A and KAT6B function is likely to be beneficial in treating cancers dependent on KAT6 activity.</p></sec><sec id="Sec12"><title>Methods</title><sec id="Sec13"><title>Mice</title><p id="Par40">All animal experiments were conducted with approval of the WEHI Animal Ethics Committee and according to the Australian code for the care and use of animals for scientific purposes. Mice were kept in a 14&#x02009;h light/10&#x02009;h dark cycle. Noon of the day the vaginal copulation plug was first observed was defined as embryonic day 0.5 (E0.5).</p></sec><sec id="Sec14"><title>Mouse alleles</title><p id="Par41">The <italic>Kat6a</italic> null allele used in this study lacked exons 5 to 9 and has been described previously<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. KAT6B overexpression transgenic mice were generated by microinjected into mouse pronuclei using bacterial artificial chromosome (BAC) <italic>pBACe3.6</italic> clone <italic>RP23-360F23</italic> to produce a germline founder. BAC clone <italic>RP23-360F23</italic> includes the complete wild-type <italic>Kat6b</italic> gene, as well as 21&#x02009;kb 5&#x02019; and 42&#x02009;kb 3&#x02019; containing regulatory sequences. Seven copies of the <italic>BAC</italic> inserted into the mouse genome to result in an ~4-fold increase in <italic>Kat6b</italic> expression as described previously<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. Mice were maintained on a <italic>FVB</italic> x <italic>BALB/c</italic> hybrid background as <italic>Kat6b</italic> overexpressing mice were not viable on inbred backgrounds. Mice were genotyped by genomic 3-way PCR for the <italic>Kat6a</italic> allele and by simple PCR to detect the <italic>SacB</italic> gene in the backbone of <italic>pBACe3.6</italic> clone <italic>RP23-360F23</italic> using the primers listed in Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>.</p></sec><sec id="Sec15"><title>Primary mouse embryonic fibroblast (MEF)</title><p id="Par43">MEFs were derived from E14.5 foetuses and grown in Dulbecco&#x02019;s modified Eagle medium (Gibco, 11995) supplemented with 100 U/ml penicillin/streptomycin (Gibco, 15140122) and 10% foetal calf serum. Cells were cultured in at 37&#x02009;&#x000b0;C, 5% CO<sub>2</sub> and 3% O<sub>2</sub>. Cell counts were determined at each passage using a Countess<sup>TM</sup> cell counter (ThermoFisher).</p></sec><sec id="Sec16"><title>Acid histone extraction</title><p id="Par44">MEFs were washed in DPBS (Gibco, 14190144) containing 0.5&#x02009;mM sodium butyrate (Sigma, B5887) and cOmplete&#x02122; EDTA-free protease inhibitor cocktail (Roche, 11873580001), scraped using a cell scraper (Fisher Scientific, 08-100-241) and collected by centrifugation (200&#x02009;&#x000d7;&#x02009;<italic>g</italic>, 5&#x02009;min). Whole E9.5 embryos were dissected and photographed under a dissecting microscope (Zeiss) and placed into a 1.5&#x02009;ml Eppendorf tube containing 100&#x02009;&#x003bc;l DPBS with 0.5&#x02009;mM sodium butyrate (Sigma, B5887) and cOmplete&#x02122; EDTA-free protease inhibitor cocktail (Roche, 11873580001). Samples were lysed in Histone acid lysis buffer (10&#x02009;mM HEPES pH 7.9, 1.5&#x02009;mM MgCl<sub>2</sub>, 10&#x02009;mM KCl and 0.5&#x02009;mM DTT) for 30&#x02009;min at 4&#x02009;&#x000b0;C on a roller, collected by centrifugation (10,000&#x02009;&#x000d7;&#x02009;<italic>g</italic>, 10&#x02009;min) and resuspended in 0.2&#x02009;M H<sub>2</sub>SO<sub>4</sub>. Samples were incubated on ice for 1&#x02013;2&#x02009;h before being dialysed in dialysis tubing (Spectrum<sup>TM</sup> Spectra/Por Dialysis Membrane Tubing; molecular weight cut-off 20&#x02009;kDa; Fisher Scientific, 08-607-067) against 0.1&#x02009;M acetic acid (Sigma, A6283) for 1&#x02009;h at 4&#x02009;&#x000b0;C and MQ-H<sub>2</sub>O overnight at 4&#x02009;&#x000b0;C. Protein concentrations were determined using a bicinchoninic acid (BCA) assay (ThermoFisher, 23225).</p></sec><sec id="Sec17"><title>Western immunoblotting</title><p id="Par45">Acid extracted histones were run on 4&#x02013;12% Bis-Tris gels (ThermoFisher, NP0322) and transferred onto nitrocellulose membranes (Licor, 926-31090). Membranes were blocked for 1&#x02009;h at room temperature (RT) on a roller in blocking buffer (Intercept&#x000ae; (PBS); Licor, 927-70001) and probed with antibodies again H3K9ac (Epicypher, 13-0033; dilution 1:5000), H3K14ac (Abcam, ab52946; 1:1000) or H3K23ac (Millipore, 07-355; 1:5000) and pan H3 (Abcam, 10799; 1:5000) overnight at 4&#x02009;&#x000b0;C. The following morning membranes were washed in PBS&#x02009;+&#x02009;0.1% Tween-20 (Sigma, P1379) and incubated with goat anti-mouse IgG secondary (IRDye&#x000ae; 800 CW; LI-COR Biosciences 926-32210; 1:10,000) and goat anti-rabbit IgG (IRDye&#x000ae;; LI-COR Biosciences, 926-68071; 1:10,000) secondary antibodies for 1&#x02009;h at RT on a roller. Samples were imaged and analysed using an automated western blot imager software (Odyssey Imager; LI-COR Biosciences).</p></sec><sec id="Sec18"><title>Histology</title><p id="Par46">E18.5 hearts were dissected, washed in PBS and fixed overnight in 10% neutral buffered formalin. Hearts were embedded in agarose to control orientation, then dehydrated and infused with paraffin and embedded for histological sectioning and haematoxylin and eosin (H&#x00026;E) staining.</p></sec><sec id="Sec19"><title>Skeletal preparations</title><p id="Par47">Skin and internal organs were removed from E18.5 pups under a dissecting microscope (Zeiss). Pups were fixed in 4% PFA (Sigma, 158127) overnight at RT on a roller, briefly rinsed in 95% EtOH and stained overnight at RT in a solution containing 5&#x02009;ml 0.4% Alcian Blue 8 GX (w/v), 5&#x02009;ml glacial acetic acid, 70&#x02009;ml 95% EtOH, 20&#x02009;ml MQ-H<sub>2</sub>O and 100&#x02009;&#x000b5;l 0.5% Alizarin red (w/v). Samples were washed in MQ-H<sub>2</sub>O. Soft tissues were dissolved in 2% (w/v) KOH (Sigma, 221473) in H<sub>2</sub>O for 24&#x02009;h at RT on a roller. Following digestion, skeletal preparations were washed in 0.25% (w/v) KOH in H<sub>2</sub>O for 30&#x02009;min at RT on a roller, followed by ascending concentrations of glycerol (20%, 33%, 50%) in 0.25% (w/v) KOH in H<sub>2</sub>O, for 1&#x02009;h, 1&#x02009;h and overnight, respectively at RT on a roller. Prepared skeletons were stored in 50% (w/v) glycerol (Sigma, G5516) in ddH<sub>2</sub>O.</p></sec><sec id="Sec20"><title>Whole mount in situ hybridization</title><p id="Par48">Embryos used for whole-mount in situ hybridisation were fixed in 4% paraformaldehyde overnight then dehydrated through a methanol series and stored at &#x02212;20&#x02009;&#x000b0;C. After genotyping selected embryos were rehydrated through a methanol series, washed in phosphate buffer saline/Tween20, then bleached in hydrogen peroxide, washed in phosphate buffer saline/Tween20, then treated with proteinase K which was stopped by the addition of 1&#x02009;M glycine. Embryos were then prehybridised a solution of 50% Formamide/5x SSC ph4.5/ 1% SDS/ 50&#x02009;&#x000b5;g/ml yeast RNA/ 50&#x02009;&#x000b5;g/ml heparin for 1&#x02009;h. Embryos were then transferred to a fresh aliquot of the hybridisation buffer containing in vitro transcribed (Roche 11175025910), digoxigenin-labelled cRNA of the <italic>Hox</italic> gene under investigation and incubated at 55&#x02009;&#x000b0;C overnight. Then embryos were washed extensively, treated with RnaseA, blocking reagent (Roche 10057177103) and foetal bovine serum, incubated with alkaline phosphatase- labelled anti-digoxigenin antibody (Roche 11214667001) overnight, washed extensively, followed by alkaline phosphatase reaction with NBT-BCIP (Roche 11681451001) for colour development. Finally, embryos were washed and then cleared in glycerol<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. Sense and antisense probes for <italic>Hoxa3</italic>, <italic>Hoxa5</italic> and <italic>Hoxc5</italic> have been previously described<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR54">54</xref></sup>.</p></sec><sec id="Sec21"><title>Foetal liver transplantation</title><p id="Par49">E14.5 foetal livers were dissected and passed through a 40&#x02009;&#x003bc;m cell sieve (Corning, 431750). 1&#x02009;&#x000d7;&#x02009;10<sup>6</sup> cells, as determined using an automated haematology analyser (Advia 2120i, Siemens Healthineers), were injected into the tail vein of 3x irradiated recipients (2&#x02009;&#x000d7;&#x02009;550&#x02009;rad, 3&#x02009;h apart)<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>.</p></sec><sec id="Sec22"><title>Flow cytometry</title><p id="Par50">Erythrocytes were lysed by washing samples 2&#x02009;&#x000d7;&#x02009;10&#x02009;ml in a hypotonic solution (150&#x02009;mM NH<sub>4</sub>Cl, 0.1&#x02009;mM EDTA, 12&#x02009;mM NaHCO<sub>3</sub>, pH 7.2). Cells were resuspended in a FACS buffer (150&#x02009;nM NaCl, 3.7&#x02009;mM KCl, 2.5&#x02009;mM CaCl<sub>2</sub>2H<sub>2</sub>O, 1.2&#x02009;mM MgSO4&#x02022;7H<sub>2</sub>O, 0.8&#x02009;mM K<sub>2</sub>HPO<sub>4</sub>, 1.2&#x02009;mM KH<sub>2</sub>PO<sub>4</sub>, 11.5&#x02009;mM HEPES, pH 7.4) supplemented with 2% foetal calf serum and stained with conjugated antibodies (Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">2</xref>) for 1&#x02009;h on ice. Samples were washed in 3&#x02013;4&#x02009;ml FACS buffer and analysed on a flow cytometer (BD LSRFortessa<sup>TM</sup> X-20, BD) at &#x0003c;7500 events/sec. Data were analysed using flow cytometry analysis software (FlowJo version 10.7, Tree Star Inc.). Cell surface markers used to identify individual cell types are shown in Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">3</xref>.</p></sec><sec id="Sec23"><title>RNA isolation and sequencing</title><p id="Par51">Total RNA from whole E9.5 embryos was extracted using an RNA extraction kit (Qiagen RNeasy mini kit; Qiagen, 74104), according to the manufacturer&#x02019;s instructions and including the optional DNaseI digestion step. RNA quality and quantity were assessed on an automated analyser (Tapestation 4200; Agilent, G2991BA), and 500&#x02009;ng RNA used to generate libraries using a library construction kit (TruSeq RNA prep kit v2; Illumina, RS-122-2002), according to the manufacturer&#x02019;s instructions. Samples were run on a sequencing machine (NextSeq 2000; Illumina) to give 66&#x02009;bp paired end reads.</p></sec><sec id="Sec24"><title>RNA sequencing analysis</title><p id="Par52">Reads were aligned to the Mus musculus (mm39) genome using Rsubread<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. Differential expression (DE) analyses were performed using the edgeR and limma software packages<sup><xref ref-type="bibr" rid="CR65">65</xref></sup>. Library sizes were normalised using the trimmed mean of <italic>M</italic>-values (TMM) method<sup><xref ref-type="bibr" rid="CR66">66</xref></sup> and the surrogate variable approach<sup><xref ref-type="bibr" rid="CR67">67</xref></sup> was used to adjust for unwanted variation in the data. The false discovery rate (FDR) was controlled below 0.05. R version 4.2.2 was used for all analyses.</p></sec><sec id="Sec25"><title>Cut&#x00026;Tag detection of H3K23 acetylation</title><p id="Par53">CUT&#x00026;Tag sequencing was performed on 50,000 MEFs combined with 50,000 <italic>Drosophila melanogaster</italic> S2 cells, as described in Kaya-Okur et al.<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>, with minor modifications as described in ref. <sup><xref ref-type="bibr" rid="CR69">69</xref></sup>. All buffers were prepared fresh with complete EDTA-free protease inhibitors (Roche, 11873580001) and 0.5&#x02009;mM sodium butyrate (Sigma, B5887). Per sample, 10&#x02009;&#x000b5;l concanavalin-A beads (Bangs Laboratories, BP531) were washed twice in 10 volumes binding buffer (20&#x02009;mM HEPES pH 7.5 (Sigma, 83264), 10&#x02009;mM KCl (Sigma, 60142), 1&#x02009;mM CaCl<sub>2</sub> (Sigma, 21115) and 1&#x02009;mM MnCl<sub>2</sub> (Sigma, M1787) and resuspended in 10&#x02009;&#x000b5;l binding buffer. Combined MEFs and S2 <italic>D. melanogaster</italic> cells were washed twice in 1&#x02009;ml wash buffer (20&#x02009;mM HEPES pH 7.5, 150&#x02009;mM NaCl (Sigma, 71386), 0.5&#x02009;mM spermidine (Sigma, S0266) and resuspended in 90&#x02009;&#x000b5;l wash buffer. Concanavalin-A beads and samples were combined and incubated (RT, 10&#x02009;min), immobilised using a magnetic rack (ThermoFisher, MR02) and beads resuspended in 100&#x02009;&#x000b5;l ice-cold antibody buffer (wash buffer supplemented with 0.05 % (w/v) digitonin (Merck, 300410), 2&#x02009;mM EDTA (Invitrogen, 15575020) and 0.1 % (w/v) BSA (Sigma, A8577) containing 1:100 H3K23ac (Millipore, 07-355) primary antibody. Samples were incubated overnight at 4&#x02009;&#x000b0;C. The following morning, beads were resuspended in 100&#x02009;&#x000b5;l wash buffer supplemented with 0.05% (w/v) digitonin containing 1:100 secondary antibody (Guinea pig anti-rabbit IgG, Antibodies Online, ABIN101961), incubated (RT, 1&#x02009;h), washed thrice and resuspended in 100&#x02009;&#x000b5;l ice-cold dig-300 buffer (20&#x02009;mM HEPES pH 7.5, 300&#x02009;mM NaCl, 0.5&#x02009;mM spermidine and 0.01 % (w/v) digitonin), supplemented with 1 2.5&#x02009;&#x000b5;l pAG-Tn5 (EpiCypher, 15-1017). Samples were incubated (RT, 1&#x02009;h), washed thrice, resuspended in 100&#x02009;&#x000b5;l tagmentation buffer (wash buffer supplemented with 0.01&#x02009;mM MgCl2 (Sigma, 63069) and incubated at 37&#x02009;&#x000b0;C for 1&#x02009;h. Tagmentation was stopped using 3.34&#x02009;&#x000b5;l 0.5&#x02009;M EDTA, 1&#x02009;&#x000b5;l 10% (w/v) SDS (Sigma, 71736), and 0.83&#x02009;&#x000b5;l 20&#x02009;mg/ml thermolabile proteinase K (NEB, P8111S), incubating at 37&#x02009;&#x000b0;C for 1&#x02009;h and 800&#x02009;rpm, followed by heat inactivation at 55&#x02009;&#x000b0;C for 10&#x02009;min. DNA was extracted using Ampure XP beads (Beckman, A63880), eluting in 25&#x02009;&#x000b5;l 10&#x02009;mM Tris-HCl pH&#x02009;=&#x02009;8.0 (Invitrogen, 15568025), 1&#x02009;mM EDTA and 25&#x02009;&#x000b5;g/ml RNAse A (ThermoFisher, EN0531) at 37&#x02009;&#x000b0;C for 10&#x02009;min. 10&#x02009;&#x000b5;l sample DNA elutes were used to generate sequencing libraries, which were amplified using PCR for 13 cycles. PCR products were cleaned up using 30&#x02009;&#x000b5;l Ampure XP beads and eluted in 25&#x02009;&#x000b5;l 10&#x02009;mM Tris-HCl pH 8.0. Cleaned libraries were analysed using High Sensitivity D1000 gels (Agilent, 5067- 5584) on an Agilent 2200 tape station. Libraries were sequenced using an Illumina NextSeq2000.</p></sec><sec id="Sec26"><title>Analysis of CUT&#x00026;Tag data</title><p id="Par54">All samples were composed of <italic>Mus musculus</italic> (test) and <italic>Drosophila melanogaster</italic> RNA (spike-in for normalisation<sup><xref ref-type="bibr" rid="CR70">70</xref></sup>). Furthermore, the transgenic BAC backbone samples contained the <italic>sacB</italic> gene. For alignment an index was built using Rsubread v2.18.0<sup><xref ref-type="bibr" rid="CR71">71</xref></sup> containing the mouse genome (mm39), the <italic>Drosophila</italic> genome (R655) and the <italic>sacB</italic> gene sequence. All samples were aligned to this combined genome index using Rsubread&#x02019;s align function reporting uniquely mapped reads only. All PCR duplicate reads were then marked using sambamba v0.6.6. The data was then summarised at both the species and mouse gene level. Data around mouse genes was summarised at &#x02212;1&#x02009;kbp upstream of the TSS to the TSS, transcription end site (TES) to +1kbp downstream of the TES, and the gene body (TSS to TES). Fragment counts were produced using Rsubread&#x02019;s featureCounts function. Fragments were counted if they were not a PCR duplicate and non-chimeric. Mouse genes were identified using RefSeq annotation to the mm39 genome. The analysis of each region was restricted to protein coding genes with official gene symbols. Riken, Gm (predicted), and pseudogenes were also removed. To avoid sex-based biases, the Xist gene and Y-chromosome were removed. Analysis of each region was then conducted independently. Differential analyses were conducted using the limma<sup><xref ref-type="bibr" rid="CR65">65</xref></sup> and edgeR<sup><xref ref-type="bibr" rid="CR66">66</xref></sup> software packages, versions 3.60.4 and 4.2.1 respectively.</p><p id="Par55">For each analysis, lowly abundant regions were filtered using edgeR&#x02019;s filterByExpr function with default parameters. The samples were then normalised to Drosophila melanogaster content using the following method:<list list-type="order"><list-item><p id="Par56">Calculate total <italic>drosophila</italic> content for each sample.</p></list-item><list-item><p id="Par57">Divide the above by the total filtered mouse counts for that sample.</p></list-item><list-item><p id="Par58">Divide the resulting numbers by the product of all values calculated in step 2 to the power of (1/number of samples).</p></list-item></list></p><p id="Par59">Differential analyses between genotypes were then conducted as follows.</p><p id="Par60">TSS region: the data was transformed to log<sub>2</sub>-counts per million (CPM) and sample weights were calculated using limma&#x02019;s arrayWeights function using the genebygene method<sup><xref ref-type="bibr" rid="CR72">72</xref></sup>. Linear models were fit to each region and robust empirical bayes moderated t-statistics with a trended prior variance were then applied to identify differential regions (robust limma-trend pipeline with sample weights)<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>.</p><p id="Par61">Gene body region: the data was transformed to log<sub>2</sub>CPM with associated precision weights using voom. Linear models were then fit to each genomic region, differences between groups were assessed using robust empirical bayes moderated t-statistics (robust limma-voom pipeline)<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>.</p><p id="Par62">TES region: Limma&#x02019;s voomWithQualityWeights function was applied to simultaneously transform the data to log<sub>2</sub>CPM with associated precision weights and estimate sample level weights<sup><xref ref-type="bibr" rid="CR74">74</xref></sup>. Linear models were then fit to each genomic region, differences between groups were assessed using robust empirical bayes moderated t-statistics (robust limma-voomWithQualityWeights pipeline).</p><p id="Par63">For each analysis the false discovery rate (FDR) was controlled below 5% using the Benjamini and Hochberg method.</p></sec><sec id="Sec27"><title>Statistics</title><p id="Par64">The statistical analysis methods for the RNA-sequencing and CUT&#x00026;Tag data are provided under the <italic>RNA-sequencing analysis</italic> and <italic>Analysis of CUT&#x00026;Tag data</italic> section. Other data are presented as mean&#x02009;&#x000b1;&#x02009;s.e.m. In all graphs circles represent individual mice or the average of transplant recipients that received cells from a single foetal liver donor. Statistical analyses were performed in Prism Graphpad Version 8.3.1 for Mac (GraphPad Software) and R version 4.2.2. Statistical tests employed and the number of biological replicates are stated in the figure legends.</p></sec><sec id="Sec28"><title>Reporting summary</title><p id="Par65">Further information on research design is available in the&#x000a0;<xref rid="MOESM15" ref-type="media">Nature Portfolio Reporting Summary</xref> linked to this article.</p></sec></sec><sec id="Sec29" sec-type="supplementary-material"><title>Supplementary information</title><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41467_2025_57155_MOESM1_ESM.pdf"><caption><p>Supplementary Information</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41467_2025_57155_MOESM2_ESM.pdf"><caption><p>Description of Additional Supplementary Files</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41467_2025_57155_MOESM3_ESM.xlsx"><caption><p>Supplementary Data 1</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41467_2025_57155_MOESM4_ESM.xlsx"><caption><p>Supplementary Data 2</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="41467_2025_57155_MOESM5_ESM.xlsx"><caption><p>Supplementary Data 3</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="41467_2025_57155_MOESM6_ESM.xlsx"><caption><p>Supplementary Data 4</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM7"><media xlink:href="41467_2025_57155_MOESM7_ESM.xlsx"><caption><p>Supplementary Data 5</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM8"><media xlink:href="41467_2025_57155_MOESM8_ESM.xlsx"><caption><p>Supplementary Data 6</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM9"><media xlink:href="41467_2025_57155_MOESM9_ESM.xlsx"><caption><p>Supplementary Data 7</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM10"><media xlink:href="41467_2025_57155_MOESM10_ESM.xlsx"><caption><p>Supplementary Data 8</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM11"><media xlink:href="41467_2025_57155_MOESM11_ESM.xlsx"><caption><p>Supplementary Data 9</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM12"><media xlink:href="41467_2025_57155_MOESM12_ESM.xlsx"><caption><p>Supplementary Data 10</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM13"><media xlink:href="41467_2025_57155_MOESM13_ESM.xlsx"><caption><p>Supplementary Data 11</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM14"><media xlink:href="41467_2025_57155_MOESM14_ESM.xlsx"><caption><p>Supplementary Data 12</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM15"><media xlink:href="41467_2025_57155_MOESM15_ESM.pdf"><caption><p>Reporting Summary</p></caption></media></supplementary-material>
</p></sec><sec id="Sec30" sec-type="supplementary-material"><title>Source data</title><p>
<supplementary-material content-type="local-data" id="MOESM16"><media xlink:href="41467_2025_57155_MOESM16_ESM.pdf"><caption><p>Source Data</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM17"><media xlink:href="41467_2025_57155_MOESM17_ESM.xlsx"><caption><p>Transparent Peer Review file</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Anne. K. Voss, Tim Thomas.</p></fn></fn-group><sec><title>Supplementary information</title><p>The online version contains supplementary material available at 10.1038/s41467-025-57155-4.</p></sec><ack><title>Acknowledgements</title><p>The authors would like to thank N. Blasch, L. Wilkins and K. Florides for excellent animal care; C. Burstr&#x000f6;m for expert technical assistance; S. Wilcox, K. Weston, T. Nikolaou and the Walter and Eliza Hall Histology department for exceptional service. M.I.B. was supported by an Australian Government Postgraduate Award. This work was supported by the Australian National Health and Medical Research Council through Project Grant 1160517 to T.T., Ideas Grant 2010711 to T.T., Research Fellowships 1081421 to A.K.V. and 1154970 to G.K.S. and Investigator Grant 1176789 to A.K.V.; through the Independent Research Institutes Infrastructure Support Scheme; and by the Victorian Government through an Operational Infrastructure Support Grant.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>M.I.B. and T.T. carried out experiments, performed data analyses and drafted the manuscript. Y.Y. and B.N.S. carried out experiments. A.L.G. performed the bioinformatics data analysis supervised by G.K.S. A.K.V. and T.T. conceived the project, designed experiments, performed data analyses and drafted the manuscript. All authors read and contributed to the manuscript.</p></notes><notes notes-type="peer-review"><title>Peer review</title><sec id="FPar1"><title>Peer review information</title><p id="Par66"><italic>Nature Communications</italic> thanks the anonymous reviewer(s) for their contribution to the peer review of this work. A peer review file is available.</p></sec></notes><notes notes-type="data-availability"><title>Data availability</title><p>All RNA sequencing and CUT&#x00026;Tag data has been deposited in the NCBI GEO database under accession numbers: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287243">GSE287243</ext-link> and GSE287244 [<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287244">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287244</ext-link>].&#x000a0;<xref ref-type="sec" rid="Sec30">Source data</xref> are provided with this paper.</p></notes><notes id="FPar2" notes-type="COI-statement"><title>Competing interests</title><p id="Par67">The Thomas and Voss laboratories have received research funding from CTx CRC for work unrelated to this project. All other authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Strahl</surname><given-names>BD</given-names></name><name><surname>Allis</surname><given-names>CD</given-names></name></person-group><article-title>The language of covalent histone modifications</article-title><source>Nature</source><year>2000</year><volume>403</volume><fpage>41</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1038/47412</pub-id><pub-id pub-id-type="pmid">10638745</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Strahl, B. D. &#x00026; Allis, C. D. The language of covalent histone modifications. <italic>Nature</italic><bold>403</bold>, 41&#x02013;45 (2000).<pub-id pub-id-type="pmid">10638745</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Combinatorial patterns of histone acetylations and methylations in the human genome</article-title><source>Nat. Genet.</source><year>2008</year><volume>40</volume><fpage>897</fpage><lpage>903</lpage><pub-id pub-id-type="doi">10.1038/ng.154</pub-id><pub-id pub-id-type="pmid">18552846</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Wang, Z. et al. Combinatorial patterns of histone acetylations and methylations in the human genome. <italic>Nat. Genet</italic>. <bold>40</bold>, 897&#x02013;903 (2008).<pub-id pub-id-type="pmid">18552846</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes</article-title><source>Cell</source><year>2009</year><volume>138</volume><fpage>1019</fpage><lpage>1031</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.06.049</pub-id><pub-id pub-id-type="pmid">19698979</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Wang, Z. et al. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. <italic>Cell</italic><bold>138</bold>, 1019&#x02013;1031 (2009).<pub-id pub-id-type="pmid">19698979</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Sheikh</surname><given-names>BN</given-names></name><name><surname>Akhtar</surname><given-names>A</given-names></name></person-group><article-title>The many lives of KATs&#x02014;detectors, integrators and modulators of the cellular environment</article-title><source>Nat. Rev. Genet.</source><year>2019</year><volume>20</volume><fpage>7</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1038/s41576-018-0072-4</pub-id><pub-id pub-id-type="pmid">30390049</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Sheikh, B. N. &#x00026; Akhtar, A. The many lives of KATs&#x02014;detectors, integrators and modulators of the cellular environment. <italic>Nat. Rev. Genet.</italic><bold>20</bold>, 7&#x02013;23 (2019).<pub-id pub-id-type="pmid">30390049</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Voss</surname><given-names>AK</given-names></name><name><surname>Thomas</surname><given-names>T</given-names></name></person-group><article-title>Histone lysine and genomic targets of histone acetyltransferases in mammals</article-title><source>Bioessays</source><year>2018</year><volume>40</volume><fpage>e1800078</fpage><pub-id pub-id-type="doi">10.1002/bies.201800078</pub-id><pub-id pub-id-type="pmid">30144132</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Voss, A. K. &#x00026; Thomas, T. Histone lysine and genomic targets of histone acetyltransferases in mammals. <italic>Bioessays</italic><bold>40</bold>, e1800078 (2018).<pub-id pub-id-type="pmid">30144132</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>T</given-names></name><name><surname>Voss</surname><given-names>AK</given-names></name></person-group><article-title>The diverse biological roles of MYST histone acetyltransferase family proteins</article-title><source>Cell Cycle</source><year>2007</year><volume>6</volume><fpage>696</fpage><lpage>704</lpage><pub-id pub-id-type="doi">10.4161/cc.6.6.4013</pub-id><pub-id pub-id-type="pmid">17374998</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Thomas, T. &#x00026; Voss, A. K. The diverse biological roles of MYST histone acetyltransferase family proteins. <italic>Cell Cycle</italic><bold>6</bold>, 696&#x02013;704 (2007).<pub-id pub-id-type="pmid">17374998</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Neuwald</surname><given-names>AF</given-names></name></person-group><article-title>Landsman D. GCN5-related histone N-acetyltransferases belong to a diverse superfamily that includes the yeast SPT10 protein</article-title><source>Trends Biochem. Sci.</source><year>1997</year><volume>22</volume><fpage>154</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1016/S0968-0004(97)01034-7</pub-id><pub-id pub-id-type="pmid">9175471</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Neuwald, A. F. Landsman D. GCN5-related histone N-acetyltransferases belong to a diverse superfamily that includes the yeast SPT10 protein. <italic>Trends Biochem. Sci.</italic><bold>22</bold>, 154&#x02013;155 (1997).<pub-id pub-id-type="pmid">9175471</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Arany</surname><given-names>Z</given-names></name><name><surname>Sellers</surname><given-names>WR</given-names></name><name><surname>Livingston</surname><given-names>DM</given-names></name><name><surname>Eckner</surname><given-names>R</given-names></name></person-group><article-title>E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators</article-title><source>Cell</source><year>1994</year><volume>77</volume><fpage>799</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(94)90127-9</pub-id><pub-id pub-id-type="pmid">8004670</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Arany, Z., Sellers, W. R., Livingston, D. M. &#x00026; Eckner, R. E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. <italic>Cell</italic><bold>77</bold>, 799&#x02013;800 (1994).<pub-id pub-id-type="pmid">8004670</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Edmondson</surname><given-names>DG</given-names></name><name><surname>Roth</surname><given-names>SY</given-names></name></person-group><article-title>Mammalian GCN5 and P/CAF acetyltransferases have homologous amino-terminal domains important for recognition of nucleosomal substrates</article-title><source>Mol. Cell Biol.</source><year>1998</year><volume>18</volume><fpage>5659</fpage><lpage>5669</lpage><pub-id pub-id-type="doi">10.1128/MCB.18.10.5659</pub-id><pub-id pub-id-type="pmid">9742083</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Xu, W., Edmondson, D. G. &#x00026; Roth, S. Y. Mammalian GCN5 and P/CAF acetyltransferases have homologous amino-terminal domains important for recognition of nucleosomal substrates. <italic>Mol. Cell Biol.</italic><bold>18</bold>, 5659&#x02013;5669 (1998).<pub-id pub-id-type="pmid">9742083</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Arany</surname><given-names>Z</given-names></name><name><surname>Newsome</surname><given-names>D</given-names></name><name><surname>Oldread</surname><given-names>E</given-names></name><name><surname>Livingston</surname><given-names>DM</given-names></name><name><surname>Eckner</surname><given-names>R</given-names></name></person-group><article-title>A family of transcriptional adaptor proteins targeted by the E1A oncoprotein</article-title><source>Nature</source><year>1995</year><volume>374</volume><fpage>81</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1038/374081a0</pub-id><pub-id pub-id-type="pmid">7870178</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Arany, Z., Newsome, D., Oldread, E., Livingston, D. M. &#x00026; Eckner, R. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. <italic>Nature</italic><bold>374</bold>, 81&#x02013;84 (1995).<pub-id pub-id-type="pmid">7870178</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Lundblad</surname><given-names>JR</given-names></name><name><surname>Kwok</surname><given-names>RP</given-names></name><name><surname>Laurance</surname><given-names>ME</given-names></name><name><surname>Harter</surname><given-names>ML</given-names></name><name><surname>Goodman</surname><given-names>RH</given-names></name></person-group><article-title>Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP</article-title><source>Nature</source><year>1995</year><volume>374</volume><fpage>85</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1038/374085a0</pub-id><pub-id pub-id-type="pmid">7870179</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Lundblad, J. R., Kwok, R. P., Laurance, M. E., Harter, M. L. &#x00026; Goodman, R. H. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. <italic>Nature</italic><bold>374</bold>, 85&#x02013;88 (1995).<pub-id pub-id-type="pmid">7870179</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Soskine</surname><given-names>M</given-names></name><name><surname>Tawfik</surname><given-names>DS</given-names></name></person-group><article-title>Mutational effects and the evolution of new protein functions</article-title><source>Nat. Rev. Genet.</source><year>2010</year><volume>11</volume><fpage>572</fpage><lpage>582</lpage><pub-id pub-id-type="doi">10.1038/nrg2808</pub-id><pub-id pub-id-type="pmid">20634811</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Soskine, M. &#x00026; Tawfik, D. S. Mutational effects and the evolution of new protein functions. <italic>Nat. Rev. Genet.</italic><bold>11</bold>, 572&#x02013;582 (2010).<pub-id pub-id-type="pmid">20634811</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Kasper</surname><given-names>LH</given-names></name><name><surname>Lerach</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Jeevan</surname><given-names>T</given-names></name><name><surname>Brindle</surname><given-names>PK</given-names></name></person-group><article-title>CBP/p300 double null cells reveal effect of coactivator level and diversity on CREB transactivation</article-title><source>EMBO J.</source><year>2010</year><volume>29</volume><fpage>3660</fpage><lpage>3672</lpage><pub-id pub-id-type="doi">10.1038/emboj.2010.235</pub-id><pub-id pub-id-type="pmid">20859256</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Kasper, L. H., Lerach, S., Wang, J., Wu, S., Jeevan, T. &#x00026; Brindle, P. K. CBP/p300 double null cells reveal effect of coactivator level and diversity on CREB transactivation. <italic>EMBO J.</italic><bold>29</bold>, 3660&#x02013;3672 (2010).<pub-id pub-id-type="pmid">20859256</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Yamauchi</surname><given-names>T</given-names></name><etal/></person-group><article-title>Distinct but overlapping roles of histone acetylase PCAF and of the closely related PCAF-B/GCN5 in mouse embryogenesis</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2000</year><volume>97</volume><fpage>11303</fpage><lpage>11306</lpage><pub-id pub-id-type="doi">10.1073/pnas.97.21.11303</pub-id><pub-id pub-id-type="pmid">11027331</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Yamauchi, T. et al. Distinct but overlapping roles of histone acetylase PCAF and of the closely related PCAF-B/GCN5 in mouse embryogenesis. <italic>Proc. Natl. Acad. Sci. USA</italic><bold>97</bold>, 11303&#x02013;11306 (2000).<pub-id pub-id-type="pmid">11027331</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Doyon</surname><given-names>Y</given-names></name><etal/></person-group><article-title>ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation</article-title><source>Mol. Cell</source><year>2006</year><volume>21</volume><fpage>51</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2005.12.007</pub-id><pub-id pub-id-type="pmid">16387653</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Doyon, Y. et al. ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. <italic>Mol. Cell</italic><bold>21</bold>, 51&#x02013;64 (2006).<pub-id pub-id-type="pmid">16387653</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Ullah</surname><given-names>M</given-names></name><etal/></person-group><article-title>Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes</article-title><source>Mol. Cell Biol.</source><year>2008</year><volume>28</volume><fpage>6828</fpage><lpage>6843</lpage><pub-id pub-id-type="doi">10.1128/MCB.01297-08</pub-id><pub-id pub-id-type="pmid">18794358</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Ullah, M. et al. Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes. <italic>Mol. Cell Biol.</italic><bold>28</bold>, 6828&#x02013;6843 (2008).<pub-id pub-id-type="pmid">18794358</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Voss</surname><given-names>AK</given-names></name><name><surname>Collin</surname><given-names>C</given-names></name><name><surname>Dixon</surname><given-names>MP</given-names></name><name><surname>Thomas</surname><given-names>T</given-names></name></person-group><article-title>Moz and retinoic acid coordinately regulate H3K9 acetylation, Hox gene expression, and segment identity</article-title><source>Dev. Cell</source><year>2009</year><volume>17</volume><fpage>674</fpage><lpage>686</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2009.10.006</pub-id><pub-id pub-id-type="pmid">19922872</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Voss, A. K., Collin, C., Dixon, M. P. &#x00026; Thomas, T. Moz and retinoic acid coordinately regulate H3K9 acetylation, Hox gene expression, and segment identity. <italic>Dev. Cell</italic><bold>17</bold>, 674&#x02013;686 (2009).<pub-id pub-id-type="pmid">19922872</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Voss</surname><given-names>AK</given-names></name><etal/></person-group><article-title>MOZ regulates the Tbx1 locus, and Moz mutation partially phenocopies DiGeorge syndrome</article-title><source>Dev. Cell</source><year>2012</year><volume>23</volume><fpage>652</fpage><lpage>663</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2012.07.010</pub-id><pub-id pub-id-type="pmid">22921202</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Voss, A. K. et al. MOZ regulates the Tbx1 locus, and Moz mutation partially phenocopies DiGeorge syndrome. <italic>Dev. Cell</italic><bold>23</bold>, 652&#x02013;663 (2012).<pub-id pub-id-type="pmid">22921202</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Simo-Riudalbas</surname><given-names>L</given-names></name><etal/></person-group><article-title>KAT6B Is a tumor suppressor Histone H3 Lysine 23 acetyltransferase undergoing genomic loss in small cell lung cancer</article-title><source>Cancer Res.</source><year>2015</year><volume>75</volume><fpage>3936</fpage><lpage>3945</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-14-3702</pub-id><pub-id pub-id-type="pmid">26208904</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Simo-Riudalbas, L. et al. KAT6B Is a tumor suppressor Histone H3 Lysine 23 acetyltransferase undergoing genomic loss in small cell lung cancer. <italic>Cancer Res.</italic><bold>75</bold>, 3936&#x02013;3945 (2015).<pub-id pub-id-type="pmid">26208904</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>BJ</given-names></name><etal/></person-group><article-title>Histone H3K23-specific acetylation by MORF is coupled to H3K14 acylation</article-title><source>Nat. Commun.</source><year>2019</year><volume>10</volume><fpage>4724</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-12551-5</pub-id><pub-id pub-id-type="pmid">31624313</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Klein, B. J. et al. Histone H3K23-specific acetylation by MORF is coupled to H3K14 acylation. <italic>Nat. Commun.</italic><bold>10</bold>, 4724 (2019).<pub-id pub-id-type="pmid">31624313</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>D</given-names></name><etal/></person-group><article-title>Histone acetyltransferase KAT6A upregulates PI3K/AKT signaling through TRIM24 binding</article-title><source>Cancer Res.</source><year>2017</year><volume>77</volume><fpage>6190</fpage><lpage>6201</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-17-1388</pub-id><pub-id pub-id-type="pmid">29021135</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Lv, D. et al. Histone acetyltransferase KAT6A upregulates PI3K/AKT signaling through TRIM24 binding. <italic>Cancer Res.</italic><bold>77</bold>, 6190&#x02013;6201 (2017).<pub-id pub-id-type="pmid">29021135</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="other">Bergamasco, M. I. et al. KAT6B is required for histone 3 lysine 9 acetylation and SOX gene expression in the developing brain. <italic>Life Sci. Alliance</italic><bold>8</bold>, e202402969 (2025).</mixed-citation></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Bergamasco</surname><given-names>MI</given-names></name><etal/></person-group><article-title>The histone acetyltransferase KAT6B is required for hematopoietic stem cell development and function</article-title><source>Stem Cell Rep.</source><year>2024</year><volume>19</volume><fpage>469</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2024.02.005</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Bergamasco, M. I. et al. The histone acetyltransferase KAT6B is required for hematopoietic stem cell development and function. <italic>Stem Cell Rep.</italic><bold>19</bold>, 469&#x02013;485 (2024).</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Borrow</surname><given-names>J</given-names></name><etal/></person-group><article-title>The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein</article-title><source>Nat. Genet.</source><year>1996</year><volume>14</volume><fpage>33</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1038/ng0996-33</pub-id><pub-id pub-id-type="pmid">8782817</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Borrow, J. et al. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. <italic>Nat. Genet.</italic><bold>14</bold>, 33&#x02013;41 (1996).<pub-id pub-id-type="pmid">8782817</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Viita</surname><given-names>T</given-names></name><name><surname>Cote</surname><given-names>J</given-names></name></person-group><article-title>The MOZ-BRPF1 acetyltransferase complex in epigenetic crosstalk linked to gene regulation, development, and human diseases</article-title><source>Front. Cell Dev. Biol.</source><year>2022</year><volume>10</volume><fpage>1115903</fpage><pub-id pub-id-type="doi">10.3389/fcell.2022.1115903</pub-id><pub-id pub-id-type="pmid">36712963</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Viita, T. &#x00026; Cote, J. The MOZ-BRPF1 acetyltransferase complex in epigenetic crosstalk linked to gene regulation, development, and human diseases. <italic>Front. Cell Dev. Biol.</italic><bold>10</bold>, 1115903 (2022).<pub-id pub-id-type="pmid">36712963</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Sheikh</surname><given-names>BN</given-names></name><etal/></person-group><article-title>MOZ regulates B-cell progenitors and, consequently, Moz haploinsufficiency dramatically retards MYC-induced lymphoma development</article-title><source>Blood</source><year>2015</year><volume>125</volume><fpage>1910</fpage><lpage>1921</lpage><pub-id pub-id-type="doi">10.1182/blood-2014-08-594655</pub-id><pub-id pub-id-type="pmid">25605372</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Sheikh, B. N. et al. MOZ regulates B-cell progenitors and, consequently, Moz haploinsufficiency dramatically retards MYC-induced lymphoma development. <italic>Blood</italic><bold>125</bold>, 1910&#x02013;1921 (2015).<pub-id pub-id-type="pmid">25605372</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Trecourt</surname><given-names>A</given-names></name><etal/></person-group><article-title>The KAT6B::KANSL1 fusion defines a new uterine sarcoma with hybrid endometrial stromal tumor and smooth muscle tumor features</article-title><source>Mod. Pathol.</source><year>2023</year><volume>36</volume><fpage>100243</fpage><pub-id pub-id-type="doi">10.1016/j.modpat.2023.100243</pub-id><pub-id pub-id-type="pmid">37307879</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Trecourt, A. et al. The KAT6B::KANSL1 fusion defines a new uterine sarcoma with hybrid endometrial stromal tumor and smooth muscle tumor features. <italic>Mod. Pathol.</italic><bold>36</bold>, 100243 (2023).<pub-id pub-id-type="pmid">37307879</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Murati</surname><given-names>A</given-names></name><etal/></person-group><article-title>Variant MYST4-CBP gene fusion in a t(10;16) acute myeloid leukaemia</article-title><source>Br. J. Haematol.</source><year>2004</year><volume>125</volume><fpage>601</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2141.2004.04960.x</pub-id><pub-id pub-id-type="pmid">15147375</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Murati, A. et al. Variant MYST4-CBP gene fusion in a t(10;16) acute myeloid leukaemia. <italic>Br. J. Haematol.</italic><bold>125</bold>, 601&#x02013;604 (2004).<pub-id pub-id-type="pmid">15147375</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Zack</surname><given-names>TI</given-names></name><etal/></person-group><article-title>Pan-cancer patterns of somatic copy number alteration</article-title><source>Nat. Genet.</source><year>2013</year><volume>45</volume><fpage>1134</fpage><lpage>1140</lpage><pub-id pub-id-type="doi">10.1038/ng.2760</pub-id><pub-id pub-id-type="pmid">24071852</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Zack, T. I. et al. Pan-cancer patterns of somatic copy number alteration. <italic>Nat. Genet.</italic><bold>45</bold>, 1134&#x02013;1140 (2013).<pub-id pub-id-type="pmid">24071852</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Baell</surname><given-names>JB</given-names></name><etal/></person-group><article-title>Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth</article-title><source>Nature</source><year>2018</year><volume>560</volume><fpage>253</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0387-5</pub-id><pub-id pub-id-type="pmid">30069049</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Baell, J. B. et al. Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth. <italic>Nature</italic><bold>560</bold>, 253&#x02013;257 (2018).<pub-id pub-id-type="pmid">30069049</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>S</given-names></name><etal/></person-group><article-title>Targeting KAT6A/KAT6B dependencies in breast cancer with a novel selective, orally bioavailable KAT6 inhibitor, CTx&#x02212;648/PF-9363</article-title><source>Cell Chem. Biol.</source><year>2023</year><volume>30</volume><fpage>1191</fpage><lpage>1210.e20</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2023.07.005</pub-id><pub-id pub-id-type="pmid">37557181</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Sharma, S. et al. Targeting KAT6A/KAT6B dependencies in breast cancer with a novel selective, orally bioavailable KAT6 inhibitor, CTx&#x02212;648/PF-9363. <italic>Cell Chem. Biol.</italic><bold>30</bold>, 1191&#x02013;1210.e20 (2023).<pub-id pub-id-type="pmid">37557181</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Mukohara</surname><given-names>T</given-names></name><etal/></person-group><article-title>Inhibition of lysine acetyltransferase KAT6 in ER(+)HER2(-) metastatic breast cancer: a phase 1 trial</article-title><source>Nat. Med.</source><year>2024</year><volume>30</volume><fpage>2242</fpage><lpage>2250</lpage><pub-id pub-id-type="doi">10.1038/s41591-024-03060-0</pub-id><pub-id pub-id-type="pmid">38824244</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Mukohara, T. et al. Inhibition of lysine acetyltransferase KAT6 in ER(+)HER2(-) metastatic breast cancer: a phase 1 trial. <italic>Nat. Med.</italic><bold>30</bold>, 2242&#x02013;2250 (2024).<pub-id pub-id-type="pmid">38824244</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Arboleda</surname><given-names>VA</given-names></name><etal/></person-group><article-title>De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay</article-title><source>Am. J. Hum. Genet.</source><year>2015</year><volume>96</volume><fpage>498</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2015.01.017</pub-id><pub-id pub-id-type="pmid">25728775</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Arboleda, V. A. et al. De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay. <italic>Am. J. Hum. Genet.</italic><bold>96</bold>, 498&#x02013;506 (2015).<pub-id pub-id-type="pmid">25728775</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Tham</surname><given-names>E</given-names></name><etal/></person-group><article-title>Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features</article-title><source>Am. J. Hum. Genet.</source><year>2015</year><volume>96</volume><fpage>507</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2015.01.016</pub-id><pub-id pub-id-type="pmid">25728777</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Tham, E. et al. Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features. <italic>Am. J. Hum. Genet.</italic><bold>96</bold>, 507&#x02013;513 (2015).<pub-id pub-id-type="pmid">25728777</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Clayton-Smith</surname><given-names>J</given-names></name><etal/></person-group><article-title>Whole-exome-sequencing identifies mutations in histone acetyltransferase gene KAT6B in individuals with the Say-Barber-Biesecker variant of Ohdo syndrome</article-title><source>Am. J. Hum. Genet.</source><year>2011</year><volume>89</volume><fpage>675</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2011.10.008</pub-id><pub-id pub-id-type="pmid">22077973</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Clayton-Smith, J. et al. Whole-exome-sequencing identifies mutations in histone acetyltransferase gene KAT6B in individuals with the Say-Barber-Biesecker variant of Ohdo syndrome. <italic>Am. J. Hum. Genet.</italic><bold>89</bold>, 675&#x02013;681 (2011).<pub-id pub-id-type="pmid">22077973</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>MA</given-names></name><etal/></person-group><article-title>De novo mutations of the gene encoding the histone acetyltransferase KAT6B cause Genitopatellar syndrome</article-title><source>Am. J. Hum. Genet.</source><year>2012</year><volume>90</volume><fpage>290</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2011.11.024</pub-id><pub-id pub-id-type="pmid">22265017</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Simpson, M. A. et al. De novo mutations of the gene encoding the histone acetyltransferase KAT6B cause Genitopatellar syndrome. <italic>Am. J. Hum. Genet.</italic><bold>90</bold>, 290&#x02013;294 (2012).<pub-id pub-id-type="pmid">22265017</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>T</given-names></name><name><surname>Voss</surname><given-names>AK</given-names></name><name><surname>Chowdhury</surname><given-names>K</given-names></name><name><surname>Gruss</surname><given-names>P</given-names></name></person-group><article-title>Querkopf, a MYST family histone acetyltransferase, is required for normal cerebral cortex development</article-title><source>Development</source><year>2000</year><volume>127</volume><fpage>2537</fpage><lpage>2548</lpage><pub-id pub-id-type="doi">10.1242/dev.127.12.2537</pub-id><pub-id pub-id-type="pmid">10821753</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Thomas, T., Voss, A. K., Chowdhury, K. &#x00026; Gruss, P. Querkopf, a MYST family histone acetyltransferase, is required for normal cerebral cortex development. <italic>Development</italic><bold>127</bold>, 2537&#x02013;2548 (2000).<pub-id pub-id-type="pmid">10821753</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Kraft</surname><given-names>M</given-names></name><etal/></person-group><article-title>Disruption of the histone acetyltransferase MYST4 leads to a Noonan syndrome-like phenotype and hyperactivated MAPK signaling in humans and mice</article-title><source>J. Clin. Investig.</source><year>2011</year><volume>121</volume><fpage>3479</fpage><lpage>3491</lpage><pub-id pub-id-type="doi">10.1172/JCI43428</pub-id><pub-id pub-id-type="pmid">21804188</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Kraft, M. et al. Disruption of the histone acetyltransferase MYST4 leads to a Noonan syndrome-like phenotype and hyperactivated MAPK signaling in humans and mice. <italic>J. Clin. Investig.</italic><bold>121</bold>, 3479&#x02013;3491 (2011).<pub-id pub-id-type="pmid">21804188</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Merson</surname><given-names>TD</given-names></name><etal/></person-group><article-title>The transcriptional coactivator Querkopf controls adult neurogenesis</article-title><source>J. Neurosci.</source><year>2006</year><volume>26</volume><fpage>11359</fpage><lpage>11370</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2247-06.2006</pub-id><pub-id pub-id-type="pmid">17079664</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Merson, T. D. et al. The transcriptional coactivator Querkopf controls adult neurogenesis. <italic>J. Neurosci.</italic><bold>26</bold>, 11359&#x02013;11370 (2006).<pub-id pub-id-type="pmid">17079664</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Bergamasco</surname><given-names>MI</given-names></name><etal/></person-group><article-title>Loss of KAT6B causes premature ossification and promotes osteoblast differentiation during development</article-title><source>Dev. Biol.</source><year>2025</year><volume>520</volume><fpage>141</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2025.01.012</pub-id><pub-id pub-id-type="pmid">39832706</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Bergamasco, M. I. et al. Loss of KAT6B causes premature ossification and promotes osteoblast differentiation during development. <italic>Dev. Biol.</italic><bold>520</bold>, 141&#x02013;154 (2025).<pub-id pub-id-type="pmid">39832706</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="other">Bergamasco, M. I. et al. Increasing histone acetylation improves sociability and restores learning and memory in KAT6B-haploinsufficient mice. <italic>J. Clin. Investig.</italic><bold>134</bold>, e167672 (2024).</mixed-citation></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Katsumoto</surname><given-names>T</given-names></name><etal/></person-group><article-title>MOZ is essential for maintenance of hematopoietic stem cells</article-title><source>Genes Dev.</source><year>2006</year><volume>20</volume><fpage>1321</fpage><lpage>1330</lpage><pub-id pub-id-type="doi">10.1101/gad.1393106</pub-id><pub-id pub-id-type="pmid">16702405</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Katsumoto, T. et al. MOZ is essential for maintenance of hematopoietic stem cells. <italic>Genes Dev.</italic><bold>20</bold>, 1321&#x02013;1330 (2006).<pub-id pub-id-type="pmid">16702405</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>T</given-names></name><etal/></person-group><article-title>Monocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cells</article-title><source>Genes Dev.</source><year>2006</year><volume>20</volume><fpage>1175</fpage><lpage>1186</lpage><pub-id pub-id-type="doi">10.1101/gad.1382606</pub-id><pub-id pub-id-type="pmid">16651658</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Thomas, T. et al. Monocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cells. <italic>Genes Dev.</italic><bold>20</bold>, 1175&#x02013;1186 (2006).<pub-id pub-id-type="pmid">16651658</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="other">Vanyai, H. K. et al. MOZ directs the distal-less homeobox gene expression program during craniofacial development. <italic>Development</italic><bold>146</bold>, dev175042 (2019).</mixed-citation></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Vanyai</surname><given-names>HK</given-names></name><name><surname>Thomas</surname><given-names>T</given-names></name><name><surname>Voss</surname><given-names>AK</given-names></name></person-group><article-title>Mesodermal expression of Moz is necessary for cardiac septum development</article-title><source>Dev. Biol.</source><year>2015</year><volume>403</volume><fpage>22</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2015.04.011</pub-id><pub-id pub-id-type="pmid">25912687</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Vanyai, H. K., Thomas, T. &#x00026; Voss, A. K. Mesodermal expression of Moz is necessary for cardiac septum development. <italic>Dev. Biol.</italic><bold>403</bold>, 22&#x02013;29 (2015).<pub-id pub-id-type="pmid">25912687</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Campo</surname><given-names>FM</given-names></name><name><surname>Borrow</surname><given-names>J</given-names></name><name><surname>Kouskoff</surname><given-names>V</given-names></name><name><surname>Lacaud</surname><given-names>G</given-names></name></person-group><article-title>The histone acetyl transferase activity of monocytic leukemia zinc finger is critical for the proliferation of hematopoietic precursors</article-title><source>Blood</source><year>2009</year><volume>113</volume><fpage>4866</fpage><lpage>4874</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-04-152017</pub-id><pub-id pub-id-type="pmid">19264921</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Perez-Campo, F. M., Borrow, J., Kouskoff, V. &#x00026; Lacaud, G. The histone acetyl transferase activity of monocytic leukemia zinc finger is critical for the proliferation of hematopoietic precursors. <italic>Blood</italic><bold>113</bold>, 4866&#x02013;4874 (2009).<pub-id pub-id-type="pmid">19264921</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Campo</surname><given-names>FM</given-names></name><name><surname>Costa</surname><given-names>G</given-names></name><name><surname>Lie</surname><given-names>ALM</given-names></name><name><surname>Stifani</surname><given-names>S</given-names></name><name><surname>Kouskoff</surname><given-names>V</given-names></name><name><surname>Lacaud</surname><given-names>G</given-names></name></person-group><article-title>MOZ-mediated repression of p16(INK) (4) (a) is critical for the self-renewal of neural and hematopoietic stem cells</article-title><source>Stem Cells</source><year>2014</year><volume>32</volume><fpage>1591</fpage><lpage>1601</lpage><pub-id pub-id-type="doi">10.1002/stem.1606</pub-id><pub-id pub-id-type="pmid">24307508</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Perez-Campo, F. M., Costa, G., Lie, A. L. M., Stifani, S., Kouskoff, V. &#x00026; Lacaud, G. MOZ-mediated repression of p16(INK) (4) (a) is critical for the self-renewal of neural and hematopoietic stem cells. <italic>Stem Cells</italic><bold>32</bold>, 1591&#x02013;1601 (2014).<pub-id pub-id-type="pmid">24307508</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Sheikh</surname><given-names>BN</given-names></name><etal/></person-group><article-title>MOZ (MYST3, KAT6A) inhibits senescence via the INK4A-ARF pathway</article-title><source>Oncogene</source><year>2015</year><volume>34</volume><fpage>5807</fpage><lpage>5820</lpage><pub-id pub-id-type="doi">10.1038/onc.2015.33</pub-id><pub-id pub-id-type="pmid">25772242</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Sheikh, B. N. et al. MOZ (MYST3, KAT6A) inhibits senescence via the INK4A-ARF pathway. <italic>Oncogene</italic><bold>34</bold>, 5807&#x02013;5820 (2015).<pub-id pub-id-type="pmid">25772242</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Sheikh</surname><given-names>BN</given-names></name><etal/></person-group><article-title>MOZ (KAT6A) is essential for the maintenance of classically defined adult hematopoietic stem cells</article-title><source>Blood</source><year>2016</year><volume>128</volume><fpage>2307</fpage><lpage>2318</lpage><pub-id pub-id-type="doi">10.1182/blood-2015-10-676072</pub-id><pub-id pub-id-type="pmid">27663673</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Sheikh, B. N. et al. MOZ (KAT6A) is essential for the maintenance of classically defined adult hematopoietic stem cells. <italic>Blood</italic><bold>128</bold>, 2307&#x02013;2318 (2016).<pub-id pub-id-type="pmid">27663673</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Ikuta</surname><given-names>K</given-names></name><name><surname>Weissman</surname><given-names>IL</given-names></name></person-group><article-title>Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1992</year><volume>89</volume><fpage>1502</fpage><lpage>1506</lpage><pub-id pub-id-type="doi">10.1073/pnas.89.4.1502</pub-id><pub-id pub-id-type="pmid">1371359</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Ikuta, K. &#x00026; Weissman, I. L. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. <italic>Proc. Natl. Acad. Sci. USA</italic><bold>89</bold>, 1502&#x02013;1506 (1992).<pub-id pub-id-type="pmid">1371359</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Morrison</surname><given-names>SJ</given-names></name><name><surname>Hemmati</surname><given-names>HD</given-names></name><name><surname>Wandycz</surname><given-names>AM</given-names></name><name><surname>Weissman</surname><given-names>IL</given-names></name></person-group><article-title>The purification and characterization of fetal liver hematopoietic stem cells</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1995</year><volume>92</volume><fpage>10302</fpage><lpage>10306</lpage><pub-id pub-id-type="doi">10.1073/pnas.92.22.10302</pub-id><pub-id pub-id-type="pmid">7479772</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Morrison, S. J., Hemmati, H. D., Wandycz, A. M. &#x00026; Weissman, I. L. The purification and characterization of fetal liver hematopoietic stem cells. <italic>Proc. Natl. Acad. Sci. USA</italic><bold>92</bold>, 10302&#x02013;10306 (1995).<pub-id pub-id-type="pmid">7479772</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Kiel</surname><given-names>MJ</given-names></name><name><surname>Yilmaz</surname><given-names>OH</given-names></name><name><surname>Iwashita</surname><given-names>T</given-names></name><name><surname>Yilmaz</surname><given-names>OH</given-names></name><name><surname>Terhorst</surname><given-names>C</given-names></name><name><surname>Morrison</surname><given-names>SJ</given-names></name></person-group><article-title>SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells</article-title><source>Cell</source><year>2005</year><volume>121</volume><fpage>1109</fpage><lpage>1121</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.05.026</pub-id><pub-id pub-id-type="pmid">15989959</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Kiel, M. J., Yilmaz, O. H., Iwashita, T., Yilmaz, O. H., Terhorst, C. &#x00026; Morrison, S. J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. <italic>Cell</italic><bold>121</bold>, 1109&#x02013;1121 (2005).<pub-id pub-id-type="pmid">15989959</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Osawa</surname><given-names>M</given-names></name><name><surname>Hanada</surname><given-names>K</given-names></name><name><surname>Hamada</surname><given-names>H</given-names></name><name><surname>Nakauchi</surname><given-names>H</given-names></name></person-group><article-title>Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell</article-title><source>Science</source><year>1996</year><volume>273</volume><fpage>242</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1126/science.273.5272.242</pub-id><pub-id pub-id-type="pmid">8662508</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Osawa, M., Hanada, K., Hamada, H. &#x00026; Nakauchi, H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. <italic>Science</italic><bold>273</bold>, 242&#x02013;245 (1996).<pub-id pub-id-type="pmid">8662508</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Sheikh</surname><given-names>BN</given-names></name><etal/></person-group><article-title>MOZ and BMI1 play opposing roles during Hox gene activation in ES cells and in body segment identity specification in vivo</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2015</year><volume>112</volume><fpage>5437</fpage><lpage>5442</lpage><pub-id pub-id-type="doi">10.1073/pnas.1422872112</pub-id><pub-id pub-id-type="pmid">25922517</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Sheikh, B. N. et al. MOZ and BMI1 play opposing roles during Hox gene activation in ES cells and in body segment identity specification in vivo. <italic>Proc. Natl. Acad. Sci. USA</italic><bold>112</bold>, 5437&#x02013;5442 (2015).<pub-id pub-id-type="pmid">25922517</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Sheikh</surname><given-names>BN</given-names></name><name><surname>Metcalf</surname><given-names>D</given-names></name><name><surname>Voss</surname><given-names>AK</given-names></name><name><surname>Thomas</surname><given-names>T</given-names></name></person-group><article-title>MOZ and BMI1 act synergistically to maintain hematopoietic stem cells</article-title><source>Exp. Hematol.</source><year>2017</year><volume>47</volume><fpage>83</fpage><lpage>97.e88</lpage><pub-id pub-id-type="doi">10.1016/j.exphem.2016.10.006</pub-id><pub-id pub-id-type="pmid">27773671</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Sheikh, B. N., Metcalf, D., Voss, A. K. &#x00026; Thomas, T. MOZ and BMI1 act synergistically to maintain hematopoietic stem cells. <italic>Exp. Hematol.</italic><bold>47</bold>, 83&#x02013;97.e88 (2017).<pub-id pub-id-type="pmid">27773671</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Geelen</surname><given-names>JA</given-names></name></person-group><article-title>Hypervitaminosis A induced teratogenesis</article-title><source>CRC Crit. Rev. Toxicol.</source><year>1979</year><volume>6</volume><fpage>351</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.3109/10408447909043651</pub-id><pub-id pub-id-type="pmid">389569</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Geelen, J. A. Hypervitaminosis A induced teratogenesis. <italic>CRC Crit. Rev. Toxicol.</italic><bold>6</bold>, 351&#x02013;375 (1979).<pub-id pub-id-type="pmid">389569</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Kessel</surname><given-names>M</given-names></name><name><surname>Gruss</surname><given-names>P</given-names></name></person-group><article-title>Homeotic transformations of murine vertebrae and concomitant alteration of Hox codes induced by retinoic acid</article-title><source>Cell</source><year>1991</year><volume>67</volume><fpage>89</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(91)90574-I</pub-id><pub-id pub-id-type="pmid">1680565</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Kessel, M. &#x00026; Gruss, P. Homeotic transformations of murine vertebrae and concomitant alteration of Hox codes induced by retinoic acid. <italic>Cell</italic><bold>67</bold>, 89&#x02013;104 (1991).<pub-id pub-id-type="pmid">1680565</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>van der Lugt</surname><given-names>NM</given-names></name><etal/></person-group><article-title>Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene</article-title><source>Genes Dev.</source><year>1994</year><volume>8</volume><fpage>757</fpage><lpage>769</lpage><pub-id pub-id-type="doi">10.1101/gad.8.7.757</pub-id><pub-id pub-id-type="pmid">7926765</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">van der Lugt, N. M. et al. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. <italic>Genes Dev.</italic><bold>8</bold>, 757&#x02013;769 (1994).<pub-id pub-id-type="pmid">7926765</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>van der Vlag</surname><given-names>J</given-names></name><name><surname>Otte</surname><given-names>AP</given-names></name></person-group><article-title>Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation</article-title><source>Nat. Genet.</source><year>1999</year><volume>23</volume><fpage>474</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1038/70602</pub-id><pub-id pub-id-type="pmid">10581039</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">van der Vlag, J. &#x00026; Otte, A. P. Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation. <italic>Nat. Genet.</italic><bold>23</bold>, 474&#x02013;478 (1999).<pub-id pub-id-type="pmid">10581039</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Acetylation of the Cd8 locus by KAT6A determines memory T cell diversity</article-title><source>Cell Rep.</source><year>2016</year><volume>16</volume><fpage>3311</fpage><lpage>3321</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.08.056</pub-id><pub-id pub-id-type="pmid">27653692</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Newman, D. M. et al. Acetylation of the Cd8 locus by KAT6A determines memory T cell diversity. <italic>Cell Rep.</italic><bold>16</bold>, 3311&#x02013;3321 (2016).<pub-id pub-id-type="pmid">27653692</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Lasko</surname><given-names>LM</given-names></name><etal/></person-group><article-title>Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours</article-title><source>Nature</source><year>2017</year><volume>550</volume><fpage>128</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1038/nature24028</pub-id><pub-id pub-id-type="pmid">28953875</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Lasko, L. M. et al. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours. <italic>Nature</italic><bold>550</bold>, 128&#x02013;132 (2017).<pub-id pub-id-type="pmid">28953875</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><mixed-citation publication-type="other">Sommerhalder, D. H. E. et al. First-in-human phase 1 dose escalation study of the KAT6 inhibitor PF-07248144 in patients with advanced solid tumors. <italic>J. Clin. Oncol</italic>. <bold>41</bold>, 1054&#x02013;1054 (2023).</mixed-citation></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>T</given-names></name><name><surname>Loveland</surname><given-names>KL</given-names></name><name><surname>Voss</surname><given-names>AK</given-names></name></person-group><article-title>The genes coding for the MYST family histone acetyltransferases, Tip60 and Mof, are expressed at high levels during sperm development</article-title><source>Gene Expr. Patterns</source><year>2007</year><volume>7</volume><fpage>657</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1016/j.modgep.2007.03.005</pub-id><pub-id pub-id-type="pmid">17517537</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Thomas, T., Loveland, K. L. &#x00026; Voss, A. K. The genes coding for the MYST family histone acetyltransferases, Tip60 and Mof, are expressed at high levels during sperm development. <italic>Gene Expr. Patterns</italic><bold>7</bold>, 657&#x02013;665 (2007).<pub-id pub-id-type="pmid">17517537</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name></person-group><article-title>The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote</article-title><source>Nucleic Acids Res.</source><year>2013</year><volume>41</volume><fpage>e108</fpage><pub-id pub-id-type="doi">10.1093/nar/gkt214</pub-id><pub-id pub-id-type="pmid">23558742</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">Liao, Y., Smyth, G. K. &#x00026; Shi, W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. <italic>Nucleic Acids Res.</italic><bold>41</bold>, e108 (2013).<pub-id pub-id-type="pmid">23558742</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>ME</given-names></name><etal/></person-group><article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title><source>Nucleic Acids Res.</source><year>2015</year><volume>43</volume><fpage>e47</fpage><pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id><pub-id pub-id-type="pmid">25605792</pub-id>
</element-citation><mixed-citation id="mc-CR65" publication-type="journal">Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. <italic>Nucleic Acids Res.</italic><bold>43</bold>, e47 (2015).<pub-id pub-id-type="pmid">25605792</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>MD</given-names></name><name><surname>McCarthy</surname><given-names>DJ</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><fpage>139</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id><pub-id pub-id-type="pmid">19910308</pub-id>
</element-citation><mixed-citation id="mc-CR66" publication-type="journal">Robinson, M. D., McCarthy, D. J. &#x00026; Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. <italic>Bioinformatics</italic><bold>26</bold>, 139&#x02013;140 (2010).<pub-id pub-id-type="pmid">19910308</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Leek</surname><given-names>JT</given-names></name><name><surname>Storey</surname><given-names>JD</given-names></name></person-group><article-title>Capturing heterogeneity in gene expression studies by surrogate variable analysis</article-title><source>PLoS Genet.</source><year>2007</year><volume>3</volume><fpage>1724</fpage><lpage>1735</lpage><pub-id pub-id-type="doi">10.1371/journal.pgen.0030161</pub-id><pub-id pub-id-type="pmid">17907809</pub-id>
</element-citation><mixed-citation id="mc-CR67" publication-type="journal">Leek, J. T. &#x00026; Storey, J. D. Capturing heterogeneity in gene expression studies by surrogate variable analysis. <italic>PLoS Genet.</italic><bold>3</bold>, 1724&#x02013;1735 (2007).<pub-id pub-id-type="pmid">17907809</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>Kaya-Okur</surname><given-names>HS</given-names></name><etal/></person-group><article-title>CUT&#x00026;Tag for efficient epigenomic profiling of small samples and single cells</article-title><source>Nat. Commun.</source><year>2019</year><volume>10</volume><fpage>1930</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-09982-5</pub-id><pub-id pub-id-type="pmid">31036827</pub-id>
</element-citation><mixed-citation id="mc-CR68" publication-type="journal">Kaya-Okur, H. S. et al. CUT&#x00026;Tag for efficient epigenomic profiling of small samples and single cells. <italic>Nat. Commun.</italic><bold>10</bold>, 1930 (2019).<pub-id pub-id-type="pmid">31036827</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name><surname>Wichmann</surname><given-names>J</given-names></name><etal/></person-group><article-title>Loss of TIP60 (KAT5) abolishes H2AZ lysine 7 acetylation and causes p53, INK4A, and ARF-independent cell cycle arrest</article-title><source>Cell Death Dis.</source><year>2022</year><volume>13</volume><fpage>627</fpage><pub-id pub-id-type="doi">10.1038/s41419-022-05055-6</pub-id><pub-id pub-id-type="pmid">35853868</pub-id>
</element-citation><mixed-citation id="mc-CR69" publication-type="journal">Wichmann, J. et al. Loss of TIP60 (KAT5) abolishes H2AZ lysine 7 acetylation and causes p53, INK4A, and ARF-independent cell cycle arrest. <italic>Cell Death Dis.</italic><bold>13</bold>, 627 (2022).<pub-id pub-id-type="pmid">35853868</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name><surname>Orlando</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Quantitative ChIP-Seq normalization reveals global modulation of the epigenome</article-title><source>Cell Rep.</source><year>2014</year><volume>9</volume><fpage>1163</fpage><lpage>1170</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.10.018</pub-id><pub-id pub-id-type="pmid">25437568</pub-id>
</element-citation><mixed-citation id="mc-CR70" publication-type="journal">Orlando, D. A. et al. Quantitative ChIP-Seq normalization reveals global modulation of the epigenome. <italic>Cell Rep.</italic><bold>9</bold>, 1163&#x02013;1170 (2014).<pub-id pub-id-type="pmid">25437568</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name></person-group><article-title>The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads</article-title><source>Nucleic Acids Res.</source><year>2019</year><volume>47</volume><fpage>e47</fpage><pub-id pub-id-type="doi">10.1093/nar/gkz114</pub-id><pub-id pub-id-type="pmid">30783653</pub-id>
</element-citation><mixed-citation id="mc-CR71" publication-type="journal">Liao, Y., Smyth, G. K. &#x00026; Shi, W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. <italic>Nucleic Acids Res.</italic><bold>47</bold>, e47 (2019).<pub-id pub-id-type="pmid">30783653</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Empirical array quality weights in the analysis of microarray data</article-title><source>BMC Bioinform.</source><year>2006</year><volume>7</volume><fpage>261</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-7-261</pub-id></element-citation><mixed-citation id="mc-CR72" publication-type="journal">Ritchie, M. E. et al. Empirical array quality weights in the analysis of microarray data. <italic>BMC Bioinform.</italic><bold>7</bold>, 261 (2006).</mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>Law</surname><given-names>CW</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><article-title>voom: precision weights unlock linear model analysis tools for RNA-seq read counts</article-title><source>Genome Biol.</source><year>2014</year><volume>15</volume><fpage>R29</fpage><pub-id pub-id-type="doi">10.1186/gb-2014-15-2-r29</pub-id><pub-id pub-id-type="pmid">24485249</pub-id>
</element-citation><mixed-citation id="mc-CR73" publication-type="journal">Law, C. W., Chen, Y., Shi, W. &#x00026; Smyth, G. K. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. <italic>Genome Biol.</italic><bold>15</bold>, R29 (2014).<pub-id pub-id-type="pmid">24485249</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>R</given-names></name><etal/></person-group><article-title>Why weight? Modelling sample and observational level variability improves power in RNA-seq analyses</article-title><source>Nucleic Acids Res.</source><year>2015</year><volume>43</volume><fpage>e97</fpage><pub-id pub-id-type="doi">10.1093/nar/gkv412</pub-id><pub-id pub-id-type="pmid">25925576</pub-id>
</element-citation><mixed-citation id="mc-CR74" publication-type="journal">Liu, R. et al. Why weight? Modelling sample and observational level variability improves power in RNA-seq analyses. <italic>Nucleic Acids Res.</italic><bold>43</bold>, e97 (2015).<pub-id pub-id-type="pmid">25925576</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><mixed-citation publication-type="other">Mah S. Y. Y. et al. ING4 and ING5 are essential for histone H3 lysine 14 acetylation and epicardial cell lineage development. <italic>Development</italic><bold>151</bold>, dev202617 (2024).</mixed-citation></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The histone lysine acetyltransferase HBO1 (KAT7) regulates hematopoietic stem cell quiescence and self-renewal</article-title><source>Blood</source><year>2022</year><volume>139</volume><fpage>845</fpage><lpage>858</lpage><pub-id pub-id-type="doi">10.1182/blood.2021013954</pub-id><pub-id pub-id-type="pmid">34724565</pub-id>
</element-citation><mixed-citation id="mc-CR76" publication-type="journal">Yang, Y. et al. The histone lysine acetyltransferase HBO1 (KAT7) regulates hematopoietic stem cell quiescence and self-renewal. <italic>Blood</italic><bold>139</bold>, 845&#x02013;858 (2022).<pub-id pub-id-type="pmid">34724565</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>